Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Feb 22.
Published in final edited form as: J Am Coll Cardiol. 2022 Feb 22;79(7):651–661. doi: 10.1016/j.jacc.2021.11.052

Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial

Roxy Senior a, Harmony R Reynolds b, James K Min c, Daniel S Berman d, Michael H Picard e, Bernard R Chaitman f, Leslee J Shaw c, Courtney B Page g, Sajeev C Govindan h, Jose Lopez-Sendon i, Jesus Peteiro j, Gurpreet S Wander k, Jaroslaw Drozdz l, Jose Marin-Neto m, Joseph B Selvanayagam n, Jonathan D Newman b, Christophe Thuaire o, Johann Christopher p, James J Jang q, Raymond Y Kwong r, Sripal Bangalore b, Gregg W Stone s, Sean M O’Brien g, William E Boden t, David J Maron u, Judith S Hochman b, ISCHEMIA Research Group
PMCID: PMC8875308  NIHMSID: NIHMS1767313  PMID: 35177194

Abstract

Background:

Detection of ≥50% diameter stenosis left main coronary artery disease (LMD) has prognostic and therapeutic implications. Noninvasive stress imaging or an exercise tolerance test (ETT) are the most common methods to detect obstructive coronary artery disease, though stress test markers of LMD remain ill-defined.

Objectives:

We sought to identify markers of LMD as detected on coronary computed tomography angiography (CCTA), using clinical and stress testing parameters.

Methods:

This was a post hoc analysis of ISCHEMIA, including randomized and nonrandomized participants who had locally determined moderate or severe ischemia on nonimaging ETT, stress nuclear myocardial perfusion imaging, or stress echocardiography followed by CCTA to exclude LMD. Stress tests were read by core laboratories. Prior coronary artery bypass grafting was an exclusion. In a stepped multivariate model, we identified predictors of LMD, first without and then with stress testing parameters.

Results:

Among 5146 participants (mean age 63 years, 74% male), 414 (8%) had LMD. Predictors of LMD were older age (p<0.001), male sex (p<0.01), absence of prior myocardial infarction (p<0.009), transient ischemic dilatation (TID) of the left ventricle on stress echocardiography (p=0.05), magnitude of ST-segment depression on ETT (p=0.004) and peak metabolic equivalents achieved (METs) on ETT (p=0.001). The models were weakly predictive of LMD (C-index 0.643 and 0.684).

Conclusions:

In patients with moderate or severe ischemia, clinical and stress testing parameters were weakly predictive of LMD on CCTA. For most patients with moderate or severe ischemia, anatomic imaging is needed to rule out LMD.

Keywords: Stress testing, coronary CT angiography, stable ischemic heart disease, coronary artery disease

Condensed Abstract

Detection of ≥50% diameter stenosis left main coronary artery disease (LMD) has both prognostic and therapeutic implications. In this post hoc analysis of 5146 ISCHEMIA randomized and non-randomized participants, we assessed clinical and stress testing predictors of LMD on coronary CT angiography. Models for LMD demonstrated suboptimal prediction overall. Thus for most patients with moderate or severe ischemia, exclusion of LMD will require anatomic imaging with either CCTA or coronary angiography.

Introduction

Detection of significant (≥50%) left main disease (LMD) has major prognostic and therapeutic implications.(1) While the detection of obstructive coronary artery disease (CAD) is important, this is especially true of LMD because current guidelines recommend revascularization to improve survival when LMD is present.(2)

The ISCHEMIA trial, which randomized patients with moderate or severe ischemia to guideline-directed medical therapy vs guideline-directed medical therapy plus optimal revascularization, showed no statistical difference between the groups for the primary composite outcome or the secondary outcome of cardiovascular death or myocardial infarction.(3) However, patients with LMD ≥50% on computed coronary tomographic angiography (CCTA) were excluded from randomization. Hence, detection of LMD during the initial evaluation of patients with myocardial ischemia is important as revascularization remains the guideline-recommended management strategy in these patients. Previous studies that evaluated clinical or functional tests (i.e, stress test) criteria for the identification of LMD are sparse and mostly performed in small populations.(4)

The aim of this post hoc analysis of ISCHEMIA(5) was to explore the markers of LMD using clinical and noninvasive functional parameters and to identify whether functional testing modalities can predict LMD on CCTA.

Study Population

In brief, the ISCHEMIA cohort comprised patients with stable ischemic heart disease and moderate or severe ischemia on clinically indicated stress imaging or severe ischemia on exercise tolerance test (ETT) as determined by enrolling sites and read later at centralized trial core laboratories. Patients were eligible if they were clinically stable, including stable angina or silent ischemia. CCTA was performed to confirm the presence of obstructive CAD and to rule out LMD. Major exclusion criteria included estimated glomerular filtration rate (eGFR) less than 30mL/min/ 1.73m2, myocardial infarction (MI) or unstable angina within 2 months of randomization, left ventricular ejection fraction less than 35%, LMD ≥50% on CCTA, New York Heart Association class III to IV heart failure or exacerbation of chronic heart failure within 6 months, or unacceptable angina despite maximally tolerated medical therapy.(5) Enrolled patients that were not confirmed to be eligible for randomization after additional testing and core laboratory review were excluded from the trial. ISCHEMIA was funded by the National Heart, Lung, and Blood Institute. IRB approval was obtained at the Clinical Coordinating Center (NYU Grossman School of Medicine IRB) and at each coordinating center and site. All participants provided informed consent.

For this analysis, enrolled ISCHEMIA participants with available CCTA interpretation for the presence or absence of LMD and available core laboratory interpretation of ischemia severity were analyzed. Patients with prior coronary artery bypass grafts (CABG) were excluded from this analysis. Patients who had CCTA done before the study were also excluded. Figure 1 depicts how the study population was derived. Stress imaging and ETT eligibility criteria for the ISCHEMIA trial have been previously described.(5) Stress testing details are mentioned in brief below.

Figure 1. Study Flow Diagram.

Figure 1.

This analysis included participants enrolled in ISCHEMIA and either excluded from randomization or randomized in the trial. Those without a coronary CT angiogram (CCTA) were excluded, as were participants with missing data for ischemia or left main stenosis. Those with prior coronary artery bypass grafting (CABG) were excluded because the left main is often bypassed. Participants enrolled after stress cardiac magnetic resonance imaging (CMR) were excluded due to inadequate sample size to permit detailed analysis.

Stress testing

Sites were directed to screen and enroll patients with moderate or severe ischemia, as determined locally on a stress test performed for clinical indications, preferably within the prior 3 months. Stress test data (e.g., images and ECG recordings for those undergoing ETT) were transferred electronically to the relevant core laboratory. The core laboratories independently interpreted baseline stress tests for all trial participants. For stress nuclear imaging (single-photon emission computed tomography or positron-emission tomography), mild ischemia was defined as reversible ischemia affecting <10% of the myocardium (summed difference score <7 segments), moderate ischemia was defined as reversible ischemia affecting ≥10% but <14.9% of the myocardium (summed difference score ≥7–9) and severe ischemia was defined as >15% ischemia (summed difference score ≥10). For stress echocardiography, mild ischemia was defined as <3 segments with reversible wall motion abnormalities in a 16 segment left ventricular model, moderate ischemia was defined as 3 segments with severe inducible wall motion abnormalities and severe ischemia as ≥ 4 segments with severe inducible wall motion abnormalities. Exercise testing entry criteria for severe ischemia required all of the following: (1) history of stable or exercise test-induced typical angina; (2) an interpretable resting ECG (e.g., no resting ST segment depression ≥1 mm); (3) at least 2 leads showing new exercise-induced ST segment depression ≥1.5 mm or a single lead ≥2 mm as compared to the baseline tracing occurring at ≤7 METs or peak heart rate <75% of age-predicted maximum confirmed by the ECG core-lab laboratory and (4) anatomic>70% stenosis of a major coronary artery on CCTA. We did not analyze cardiac magnetic resonance (CMR) data in relation to LMD due to the low number of patients enrolled after this stress test modality.

CCTA

CCTA was interpreted centrally by a core laboratory, without regard to stress test findings or clinical information. At least two readers evaluated the presence and severity of LMD, with any disagreements resolved by the core laboratory director.

Statistical Analysis

Presence of LMD was defined as LMD stenosis ≥50%. Continuous variables are presented as medians (Q1, Q3) and differences compared using the Wilcoxon rank-sum test or Student’s t-test, as appropriate. Categorical variables are presented as counts (raw percentages) and differences compared using Pearson’s chi-square test or Fisher’s exact test if cell frequencies were not sufficient. A multivariable logistic regression model was used to assess the association between the following clinical characteristics and LMD: age at enrollment, sex, race/ethnicity, hypertension, diabetes, smoking status, prior MI and eGFR (ml/min). An additional multivariable logistic regression model assessed the association between imaging and stress test variables and disease status, adjusting for the clinical characteristics. Specific imaging and stress test variables included: the number of ischemic segments on SE, number of infarcted segments on SE, summed differences score on nuclear, TID on nuclear, TID on SE, ST depression on ETT, peak exercise METs on ETT, severe or moderate anterior ischemia on nuclear or SE and LAD and LCX ischemia on nuclear or SE. Both models combined data from imaging and ETT patients and the latter model included a sex by modality interaction term. Multiple imputation by chained equations was used to impute missing covariates for the logistic regression models. Imaging and stress test variables were set to a constant value for patients that did not undergo the particular test; the odds ratios for the imaging and stress test indicators are not reported due to lack of interpretability. The model’s ability to distinguish between patients with relatively high versus low likelihood of LMD > 50% was assessed by calculating the C-index and by plotting the distribution of predicted probabilities of LMD > 50% within each modality. Predicted probabilities of LMD >50% from the full model were further analyzed with the goal of identifying non-rare subgroups with a low average probability of LMD >50%. The search for subgroups was performed both in the combined cohort and separately within each modality. In the combined cohort, candidate subgroup factors included all predictor variables with a p-value <0.2 in the full multivariable model plus the core-laboratory determined degree of ischemia (none/mild/moderate/severe). In modality-specific analyses, we used modality-specific predictors in place of the degree of ischemia. Subgroups were identified by calculating the average predicted probability of LMD >50% across patients within each level of each candidate subgroup factor and within groups formed by the cross-classification of 2 or more candidate subgroup factors. Subgroups were reported here if they included at least 350 patients and if the average predicted probability was ≤2.5%. To account for statistical uncertainty in these estimates, we present results along with 95% bootstrap confidence intervals.

RESULTS

A total of 5146 patients were enrolled after stress testing who underwent CCTA, who did not have prior CABG, and had interpretable ischemia testing using a modality other than CMR imaging (Figure 1), of whom 414 (8.0%) had LMD. The median age was 63 years and 74% were males (Table 1). Participants with LMD were older, more likely to be male, of Asian ethnicity, and had a lower prevalence of prior MI and lower median eGFR. There was no meaningful difference between those with or without LMD in the prevalence of diabetes mellitus, systemic hypertension and history of smoking. The proportion of LMD patients undergoing nuclear imaging, stress echocardiography and ETT were 38%, 22% and 40%, respectively (p<0.001 vs. without LM). Those with LMD had a greater degree of inducible ischemia than those without LMD, on all stress test modalities. Transient ischemic dilatation (TID) was observed more often in patients with as compared to those without LMD among those undergoing stress echocardiography but not significantly more often in patients undergoing nuclear imaging. Patients with LMD had a lower exercise capacity on ETT than those without LMD. The proportion of LMD patients with moderate or severe anterior ischemia was higher among patients undergoing stress echocardiography and nuclear imaging. The proportions of patients with ischemia in both the left anterior descending (LAD) and circumflex (LCX) territories were not different in patients with and without LMD by nuclear imaging but were significantly more in LMD group by stress echocardiography. Among patients who underwent nuclear imaging, 45% underwent exercise testing and 55% received pharmacological agents; the proportions in stress echocardiography were 77% and 23%, respectively. Exercise hemodynamics were not routinely available for stress imaging tests.

TABLE 1.

Baseline Clinical Characteristics of the Study Population with and without LMD

Characteristic Overall N= 5146 Left main stenosis ≥ 50%
N=414
No Left main stenosis ≥ 50%
N=4732
P-Value
Demographics
Age at Enrollment 63.4 (56.6 – 69.7) 64.6 (59.1 – 70.5) 63.3 (56.4 – 69.7) <.001
Male 3816 (74.2%) 367 (88.6%) 3449 (72.9%) <.001
Race/Ethnicity 0.008
 Non-Hispanic White 2464/4769 (51.7%) 189/384 (49.2%) 2275/4385 (51.9%)
 Non-Hispanic Asian 1310/4769 (27.5%) 130/384 (33.9%) 1180/4385 (26.9%)
 Other 995/4769 (20.9%) 65/384 (16.9%) 930/4385 (21.2%)
Cardiovascular Risk Factors
Hypertension 3472/5120 (67.8%) 268/412 (65.0%) 3204/4708 (68.1%) 0.210
Diabetes 1888 (36.7%) 146 (35.3%) 1742 (36.8%) 0.531
Cigarette Smoking 0.693
 Never Smoked 2365/5017 (47.1%) 187/380 (49.2%) 2178/4637 (47.0%)
 Former Smoker 2021/5017 (40.3%) 148/380 (38.9%) 1873/4637 (40.4%)
 Current Smoker 631/5017 (12.6%) 45/380 (11.8%) 586/4637 (12.6%)
Cardiovascular Disease History
Prior MI 684/5106 (13.4%) 36/400 (9.0%) 648/4706 (13.8%) 0.007
Baseline Labs
eGFR (ml/min) 86 (73 – 101) 83 (73 – 99) 86 (73 – 101) 0.511
Imaging and Stress Test
Modality <.001
 Nuclear SPECT/PET 2286 (44.4%) 158(38.2%) 2128 (45.0%)
 SE 1279 (24.9%) 89 (21.5%) 1190 (25.0%)
 ETT 1581(30.7%) 167 (40.3%) 1414 (29.9%)
Number of ischemic segments on SE 4 (3 – 5) 4 (3 – 6) 4 (3 – 5) 0.008
Number of infarcted segments on SE 0 (0 – 0) 0 (0 – 0) 0 (0 – 0) 0.311
Summed difference score on SPECT 8 (7 – 11) 9 (7 – 12) 8 (7 – 11) <.001
Summed stress score on SPECT 9 (7 – 14) 11 (8 – 15) 9 (7 – 14) 0.007
TID (Transient ischemic dilation in the LV) on SPECT 309/2286 (13.5%) 26/158 (16.5%) 283/2128 (13.3%) 0.263
TID (Transient ischemic dilation in the LV) on SE 349/1279 (27.3%) 38/89 (42.7%) 311/1190 (26.1%) <.001
Maximum ST Depression in Any Lead on ETT, mm 2.5 (2.0 – 3.1) 2.7 (2.2 – 3.3) 2.4 (2.0 – 3.1) 0.001
Peak METs on ETT <.001
 < 7 579/1167 (49.6%) 48/68 (70.6%) 531/1099 (48.3%)
 ≥ 7 588/1167 (50.4%) 20/68 (29.4%) 568/1099 (51.7%)
Severe or moderate anterior ischemia on SPECT 683/2285 (29.9%) 58/158 (36.7%) 625/2127 (29.4%) 0.052
Severe or moderate anterior ischemia on SE 422/1277 (33.0%) 40/89 (44.9%) 382/1188 (32.2%) 0.013
LAD + LCX ischemia on SPECT 201/2286 (8.8%) 16/158 (10.1%) 185/2128 (8.7%) 0.539
LAD + LCX ischemia on SE 211/5146 (4.1%) 22/89 (24.7%) 189/1190 (15.9%) 0.03
Coronary Anatomy on CCTA
Number of Diseased Vessels with ≥70% stenosis <.001
 0 1016/5146 (19.7) 15/414 (3.6) 1001/4732 (21.2)
 1 1048/5146 (20.4) 49/414 (11.8) 999/4732 (21.1)
 2 776/5146 (15.1) 97/414 (23.4) 679/4732 (14.3)
 3 551/5146 (10.7) 113/414 (27.3) 438/4732 (9.3)
 Non-evaluable 1755/5146 (34.1) 140/414 (33.8) 1615/4732 (34.1)
Multi-vessel Disease with ≥70% stenosis <.001
 No 2511/5146 (48.8) 86/414 (20.8) 2425/4732 (51.2)
 Yes 1633/5146 (31.7) 256/414 (61.8) 1377/4732 (29.1)
 Not evaluable 1002/5146 (19.5) 72/414 (17.4) 930/4732 (19.7)

Continuous variables are presented as medians (Q1, Q3) and categorical variables are presented as counts (column percentages). The number of diseased vessels was not evaluable if pre-determined key segments were not interpretable for stenosis severity.

Logistic regression analysis (Table 2) indicated that among clinical factors, older age, male sex, Asian race and lack of prior MI were the only significant predictors of LMD. The C index for the clinical logistic model was 0.643. Among imaging and exercise parameters, after adjusting for clinical factors (Table 3), significant predictors of LMD were older age, male sex, lack of prior MI, greater ST depression and lower peak METs on ETT and TID on stress echocardiography. Nuclear imaging parameters were not independently associated with LMD. The C index for this model was only marginally but statistically significantly improved compared with the clinical model, to 0.684 (p<0.001). Sensitivity analysis performed after excluding patients with prior MI showed that TID on stress echocardiography was no longer significant, with no change in C-index.

TABLE 2 -.

RESULTS FROM CLINICAL LOGISTIC MODEL FOR LMD

Left main stenosis ≥ 50%
Variable OR 95% CI P-value
Age at Enrolment, years1 <.001
65 versus 55 1.42 1.21 – 1.66
75 versus 55 1.56 1.21 – 2.01
Female Sex 0.32 0.24 – 0.44 <.001
Race/Ethnicity 0.028
Non-Hispanic White ref
Non-Hispanic Asian 1.34 1.04 – 1.73
Other 0.90 0.67 – 1.2
Hypertension 0.93 0.74 – 1.18 0.560
Diabetes 0.88 0.71 – 1.1 0.268
Cigarette Smoking 0.219
Never Smoked ref
Former Smoker 0.81 0.64 – 1.03
Current Smoker 0.92 0.65 – 1.3
Prior MI 0.61 0.42 – 0.88 0.008
eGFR (ml/min)1 0.908
60 versus 120 1.05 0.76 – 1.44
90 versus 120 0.98 0.77 – 1.24
1

Modeled as a restricted cubic spline

C-index for Left main stenosis ≥ 50%: 0.643

TABLE 3.

RESULTS FROM STRESS TEST MODEL FOR LMD ADJUSTING FOR CLINICAL FACTORS

Left main stenosis ≥ 50%
Clinical Variables OR 95% CI P-value
Age at Enrolment, years 1 <.001
65 versus 55 1.40 1.19 – 1.65
75 versus 55 1.56 1.21 – 2.01
Female Sex among nuclear modality 0.26 0.14 – 0.48 <.001
Race/Ethnicity 0.489
Non-Hispanic White ref
Non-Hispanic Asian 1.01 0.74 – 1.37
Other 0.84 0.62 – 1.14
Hypertension 0.95 0.75 – 1.2 0.681
Diabetes 0.87 0.70 – 1.09 0.217
Cigarette Smoking 0.36
Never Smoked ref
Former Smoker 0.84 0.66 – 1.07
Current Smoker 0.97 0.67 – 1.35
Prior MI 0.61 0.42 – 0.88 0.009
eGFR (ml/min)1 0.977
60 versus 120 1.03 0.74 – 1.43
90 versus 120 1.00 0.78 – 1.27
Stress Test Variables
Number of ischemic segments on stress echo, per 1 segment increase 1.10 0.96 – 1.25 0.158
Number of infarcted segments on stress echo, per 1 segment increase 1.08 0.94 – 1.25 0.268
Summed difference score on nuclear ≥ 10 1.49 0.95 – 2.33 0.080
Summed stress score on nuclear 1.00 0.96 – 1.04 0.977
TID (Transient ischemic dilation in the LV) on nuclear 1.01 0.63 – 1.62 0.965
TID (Transient ischemic dilation in the LV) on stress echo 1.63 1 – 2.66 0.049
Maximum ST Depression in Any Lead on ETT, per 1 mm increase 1.28 1.08 – 1.52 0.004
Peak exercise METs on ETT 3 <.001
Peak exercise METs up to 5 0.82 0.58 – 1.17
Peak exercise METs above 5 0.74 0.63 – 0.86
Severe or Moderate Anterior Ischemia on nuclear 1.32 0.91 – 1.92 0.141
Severe or Moderate Anterior Ischemia on stress echo 1.04 0.58 – 1.84 0.904
LAD + LCX ischemia on nuclear 1.32 0.76 – 2.32 0.327
LAD + LCX ischemia on stress echo 1.24 0.69 – 2.22 0.475
1

Modeled as a restricted cubic spline.

2

Note: There is a sex by modality interaction term in model. The odds ratios for modality by sex are not presented in this table due to the modality specific covariates.

The sex by modality interaction p-value in LM>= 50% model is: 0.15

3

Modeled as a linear spline.

Cindex for Left main stenosis ≥ 50%: 0.684

Joint test for Imaging and Stress Test variables is: <.001

ETT = exercise tolerance testing (non-imaging); METs = metabolic equivalents achieved during stress testing

Analysis was also performed based on ≥70% LMD (n=82 patients). The proportion of enrolled participants with ≥70% LMD was 1.1% with nuclear imaging, 1.3% with stress echocardiography and 2.7% with ETT (p<0.001). Due to the limited number of patients with LMD, only modality-specific variables were included in the models; clinical characteristics were not included as adjustment variables. ETT parameters of ST depression (p=0.02) and lower peak workload (p=0.04) were associated with ≥70% LMD, but neither nuclear nor stress echocardiography data provided incremental information over clinical parameters in ≥70% LMD prediction.

Figure 2 illustrates the distribution of the predicted risk estimates of LMD, ranging from less than 2% through over 30%, by stress test modality. Tables 4 and 5 depict the subgroups defined by combinations of clinical and imaging parameters that were associated with less than 2.5% probability of LMD on average. Table 4 shows the combined effect of nuclear and stress echocardiography on the model, with ischemia categorized as severe, moderate, mild or none. The variables considered were age, sex, prior MI and the degree of ischemia. The simplest combination of clinical features that excluded LMD with more than 97.5% probability on average in an adequately sized subgroup was female sex with mild or moderate ischemia (Central Illustration). Among remaining participants (women with severe ischemia, and men), the prevalence of LMD was 8.9%. Table 5 shows the modality-specific parameters (nuclear, stress echocardiography, ETT) associated with LMD. Clinical variables were the same as in the clinical analysis in Table 4. There were no ETT subgroups of the specified size with ≤2.5% predicted likelihood of LMD.

Figure 2. Distribution of the predicted risk estimates of left main disease (LMD).

Figure 2.

The sample was stratified by qualifying stress test modality, whether nuclear, echocardiography (echo) or exercise tolerance testing (ETT). The predicted risk of significant LMD, defined as ≥50% on coronary CT angiography, ranged from less than 2% through over 30%. The proportion of participants with each level of predicted risk is shown.

TABLE 4.

SUBGROUPS WITH AN AVERAGE MODEL-PREDICTED PROBABILITY OF LMD THAT IS ≤ 2.5% (COMBINED COHORT)

Subgroup definition N Mean Predicted Probability (Bootstrapped 95% confidence interval)
Female; No, Mild or Moderate Ischemia 673 0.023 (0.019–0.024)
Female; Mild or Moderate Ischemia 577 0.023 (0.019–0.024)
Female; Mild or Moderate Ischemia; Age ≤ 75 501 0.022 (0.018–0.023)
Female; Mild or Moderate Ischemia; Age > 55 480 0.024 (0.020–0.025)
Female; Moderate Ischemia 444 0.024 (0.020–0.025)
Female; Moderate Ischemia; Age > 55 376 0.025 (0020–0.026)

The following variables were used to define subgroups: Sex, age (categorized as ≤55, ≤65, and ≤75), prior MI and degree of ischemia (none, none/mild, none/mild/moderate). Only subgroups including at least 350 participants were considered.

TABLE 5.

SUBGROUPS WITH AN AVERAGE MODEL-PREDICTED PROBABILITY OF LMD THAT IS ≤ 2.5% DEFINED USING MODALITY SPECIFIC VARIABLES

Subgroup definition N Mean Predicted Probability (Bootstrapped 95% confidence interval)
Female; Nuclear 508 0.024 (0.018–0.026)
Female; Stress Echo 446 0.025 (0.019–0.028)
Female; Nuclear; Summed difference score <10 389 0.021 (0.016–0.023)
Female; Stress Echo; Number of ischemic segments ≤5 361 0.021 (0.016–0.024)

The following variables were used to define subgroups: Sex, age (categorized as ≤55, ≤65, and ≤75), prior MI, imaging modality (Nuclear, Stress Echo, and ETT). Modality specific variables included: Summed difference score on Nuclear≥ 10; Severe or Moderate Anterior Ischemia on Nuclear; Number of ischemic segments (categorized as ≤3, ≤5) on Stress Echo; TID (Transient ischemic dilation in the LV) on Stress Echo; Maximum ST Depression in Any Lead on ETT (categorized as ≤2, ≤3). Only subgroups including at least 350 participants were considered.

Central Illustration. LMD in Patients with Moderate or Severe Ischemia.

Central Illustration.

Enrolled participants in ISCHEMIA had moderate or severe ischemia on a stress test (e.g., stress echocardiography, upper left, stress nuclear, upper right of stress test panel, or exercise tolerance testing, bottom left). Those with LMD on coronary computed tomography angiography (CCTA) after enrollment were excluded from randomization.

Top right histogram, distribution of predicted probability of LMD among females without severe ischemia.Half of the patients in this subgroup had predicted probability of LMD >2.1%.

Histogram, bottom right, distribution of predicted probability of LMD among males with any degree of ischemia, or among females with severe ischemia.”

Discussion

This large study assessed commonly used non-invasive stress modalities for the prediction of significant LMD as assessed by CCTA among patients with a relatively high likelihood of LMD, approximately 8%. We demonstrated that stress testing offered only modest incremental value over clinical parameters for prediction of LMD in this cohort of patients with moderate or severe ischemia as determined by sites on clinically indicated stress testing before enrollment in the ISCHEMIA trial. Overall, the predictive value was suboptimal. ISCHEMIA showed that high-risk stable ischemic heart disease patients with significant inducible ischemia on noninvasive testing did not have a statistically lower rate of the composite primary outcome or of cardiovascular death and MI when routine revascularization was added to guideline-directed medical therapy as compared to guideline-directed medical therapy alone.(3) Application of these results to clinical practice, however, may be challenging when LMD status is not known, since patients with LMD were excluded from randomization in the ISCHEMIA trial. Though the results of ISCHEMIA and other strategy trials(6,7) indicate that the majority of patients without LMD can be managed conservatively, it is nonetheless important to exclude LMD. Available studies indicate that patients with LMD benefit from revascularization, though these trials predated effective medical therapy for risk reduction.(8) A pre-trial survey of cardiologists indicated a lack of equipoise regarding revascularization for LMD.(9)

Previous studies have identified stress testing parameters that are associated with higher likelihood of LMD. To our knowledge, this is the first study attempting to identify predictors of LMD among patients with clinically diagnosed moderate or severe ischemia, a group with a relatively high likelihood of LMD. In contrast, the prevalence of LMD in the CONFIRM registry in patients with suspected angina without known CAD was only 0.9%. (10) We found that stress test parameters were not adequate for ruling out LMD. Though TID on stress echocardiography and severe ST depression and low workload on ETT were independent predictors of LMD beyond clinical variables and independent of other imaging markers of LMD disease, their incremental predictive value was modest. The imaging findings are consistent with other, smaller studies(4) and can be explained by the fact that in LMD, hyperemic blood flow is rarely affected to the same degree in the LAD and left circumflex territory. Indeed, distal LMD disease may preferentially reduce blood flow in the LAD as the plaque frequently extends into the LAD vs left circumflex territory.(11) Furthermore, it is recognized that it may be difficult to discriminate LMD from the disease in the LAD and left circumflex coronary arteries without LMD commonly known as left main equivalent.(12) Patients with LMD have a high prevalence of associated multivessel disease. This is highly relevant in the ISCHEMIA trial, in which 66% of patients undergoing CCTA had multivessel CAD.(3)

There are also imaging specific issues that may have affected the discriminatory power of the imaging modalities. Nuclear imaging (particularly SPECT, which was the major nuclear modality in the ISCHEMIA trial) depends on a relative myocardial blood flow difference of at least 2:1 ratio to detect reduced perfusion. Thus, differential reduction in flow in the LAD vs left circumflex territory may not be detected. On the other hand, a similar reduction in perfusion in large areas of the left ventricle (balanced ischemia) may result in normalization of tracer uptake in ischemic segments and thus may underestimate ischemia.(13) Perfusion defect patterns in these studies identified only 19%−29% of patients with LMD.(14) The sensitivity of SPECT compared to stress echocardiography for the detection of LMD tended to be lower for the same reasons as stated above.(4,14). Exercise stress echocardiography has previously been reported to have similar high sensitivity for the detection of LMD compared to dobutamine stress echocardiography.(15) In our study, neither stress echocardiography nor SPECT demonstrated a significant relationship between increasing ischemia severity and LMD.

Transient ischemic dilation as detected by stress echocardiography, but not SPECT, was independently associated with LMD. Transient ischemic dilation was more commonly observed during stress echocardiography than during nuclear imaging in this study, perhaps related to a greater proportion of patients undergoing exercise rather than pharmacological stress with stress echocardiography in contrast with the proportions used for nuclear imaging.(15) It is noteworthy that exercise-induced ST depression and reduced workload by ETT was associated with LMD. Unfortunately, we could not analyze exercise time and hemodynamics in patients undergoing stress imaging in this study, and therefore cannot comment on whether these parameters would have refined risk prediction.

Given that the presence of LMD is a critical factor in selection for revascularization, particularly after publication of the main ISCHEMIA results, we explored clinical and stress test variables that could be used in combination to rule out LMD. Female sex alone was significantly associated with lower likelihood of LMD in patients with moderate or severe ischemia on either nuclear imaging or stress echocardiography, but female patients undergoing exercise tolerance testing had a slightly higher probability of LMD not meeting our predetermined threshold. Further, there was substantial variability in predicted risk of LMD even within the lower risk female subsets. There was no subgroup of men with low likelihood of LMD meeting our predetermined sample size, regardless of stress testing results. The subgroups with the lowest average risk of LMD were female sex with induced ischemia with <10 score by stress nuclear and female sex with <5 segments by stress echocardiography. Unfortunately, these two subgroups were small, 7.6% and 7%, respectively. Our finding of lower likelihood of LMD in patients with prior MI may be related to anatomic coronary imaging at the time of the prior MI; if LMD was found then, the patient would not be considered eligible for the trial.

Limitations

We analyzed left main stenosis using the 50% threshold, but not all 50–70% left main stenosis may be flow limiting. The population studied was comprised of patients who were enrolled following site-interpreted moderate or severe ischemia by imaging or severe ischemia ETT criteria, and on core laboratory review, 24% of stress imaging tests submitted by sites showed mild or no ischemia, and 23% of ETTs showed less than severe ischemia.(16)These proportions were higher than in the randomized trial cohort.(16) Exercise hemodynamic data were not available in enough patients with stress imaging to permit inclusion into this analysis. We used CCTA to define LMD. It is known that CCTA and invasive coronary angiography may not yield identical results due to inherent differences in the techniques. CCTA may overestimate stenosis severity(12). Calcification may also obscure stenosis assessment by CCTA. Our sites did not use echocardiography to identify flow in the LM coronary artery, though movement artifact can compromise its ability to consistently image the LM(17). In another post-hoc analysis of the ISCHEMIA trial despite high concordance (97.1%), when the 1728 patients in whom CCTA showed no significant left main disease underwent invasive coronary angiography, 2.9% of patients had ≥50% LMD, which may have implications regarding which anatomic testing may be performed for the exclusion of LMD.(12)

Conclusions

In patients with moderate or severe inducible ischemia who underwent CCTA in this analysis, the prevalence of left main stenosis ≥50% was 8%. Transient ischemic dilation by stress echocardiography, and the magnitude of ST depression and low achieved workload by ETT, were associated with LMD independent of clinical factors, but the discriminatory capacity of the model was modest. Women with a lower burden of ischemia by either stress nuclear or stress echocardiography had a very low predicted likelihood of LMD, on average 2.3%. Thus for most patients with moderate or severe ischemia, exclusion of LMD will require anatomic imaging with either CCTA or invasive coronary angiography.

Clinical Implications

It is desirable for clinicians to know whether a patient with stable ischemic heart disease has significant left main stenosis because guidelines recommend revascularization to improve survival in patients with LMD. Among patients with moderate-severe ischemia who were considered for initial conservative therapy, clinical and stress testing parameters were inadequate for ruling out LMD with a high degree of certainty overall. There was high concordance of CCTA and invasive angiography for LMD in ISCHEMIA. Thus for most patients, exclusion of LMD will require anatomic imaging, with CCTA or conventional invasive angiography.

CLINICAL PERSPECTIVES.

Competency in Medical Knowledge:

Among patients with moderate or severe ischemia on stress testing, the likelihood of left main coronary artery disease (LMD) is 8%, but the predictive value of clinical assessment and stress testing is limited, and anatomic imaging is necessary for accurate identification of LMD.

Translational Outlook:

Subgroups of patients with LMD in prior trials comparing revascularization to medical therapy have been small in size and predated effective preventive medical therapy. Future trials may consider inclusion of patients with LMD.

Sources of Funding:

NIH grants U01HL105907, U01HL105462, U01HL105561, U01HL105565

Disclosure Statements:

Dr. Roxy Senior reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Dr. Harmony R. Reynolds reports grants from National Heart, Lung, and Blood Institute during the conduct of the study; non-financial support from Abbott Vascular, non-financial support from Siemens, non-financial support from BioTelemetry, outside the submitted work;

Dr. James K. Min reports grants from National Heart, Lung and Blood Institute during the conduct of the study; also receives grants from CLEERLY INC., GE HEALTHCARE ARINETA, outside the submitted work.

Dr. Daniel S. Berman reports grants from National Heart, Lung, and Blood Institute during the conduct of the study; reports grants from GE, CSMC Heartflow, and Bayer; receives software royalties from Cedars-Sinai Medical Center outside the submitted work.

Dr. Michael H. Picard reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Dr. Bernard R. Chaitman reports grants from National Heart, Lung, and Blood Institute during the conduct of the study; personal fees from Merck, NovoNordisk, Lilly,Johnson and Johnson, Daiichi Sankyo, Imbria, Xylocor, Sanofi, Tricida, and Xylocor outside the submitted work;

Dr. Leslee J. Shaw reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Courtney B. Page reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Dr. Sajeev C. Govindan reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Dr. Jose Lopez Sendon reports grants from National Heart, Lung, and Blood Institute during the conduct of the study; grants from Bayer, Merck and Amgen; grants and personal fees from Pfizer, Menarini, Sanofi, Boeringher Infleheim outside the submitted work. Dr. Jesus Peteiro reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Dr. Gupreet S. Wander reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Dr. Jaroslaw Drozdz reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Dr. Jose Marin-Neto reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Dr. Joseph B. Selvanayagam reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Dr. Jonathan D. Newman reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Dr. Christophe Thuaire reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Dr. Johann Christopher reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Dr. James J. Jang reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Dr. Raymond Y. Kwong reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Dr. Sripal Bangalore reports grants from National Heart, Lung, and Blood Institute, during the conduct of the study; grants and personal fees from Abbott Vascular, personal fees from Biotronik, Pfizer, Amgen, and Reata outside the submitted work.

Dr. Gregg W. Stone reports grants and personal fees from National Heart, Lung, and Blood Institute, during the conduct of the study; personal fees from Terumo, personal fees from Amaranth, personal fees from Shockwave, personal fees and other from Valfix, personal fees from TherOx, personal fees from Reva, personal fees from Vascular Dynamics, personal fees from Robocath, personal fees from HeartFlow, personal fees from Gore, personal fees from Ablative Solutions, personal fees from Matrizyme, personal fees from Miracor, personal fees from Neovasc, personal fees from V-wave, personal fees from Abiomed, personal fees from Claret, personal fees from Sirtex, personal fees and other from Ancora, personal fees and other from Qool Therapeutics, other from Cagent, other from Applied Therapeutics, other from Biostar family of funds, other from MedFocus family of funds, personal fees and other from SpectraWave, personal fees from MAIA Pharmaceuticals, personal fees and other from Orchestra Biomed, other from Aria, personal fees from Vectorious, other from Cardiac Success, outside the submitted work;

Dr. Sean M. O’Brien reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Dr. William E. Boden reports grants from National Heart, Lung, and Blood Institute, during the conduct of the study; grants from Abbvie, grants from Amarin, grants from Amgen, personal fees from Amgen, personal fees from Cleveland Clinic Clinical Coordinating Center, personal fees from Janssen, outside the submitted work;

Dr. David J. Maron reports grants from National Heart, Lung, and Blood Institute during the conduct of the study.

Dr. Judith S. Hochman is PI for the ISCHEMIA trial for which, in addition to support by National Heart, Lung, and Blood Institute grant, devices and medications were provided by Abbott Vascular; Medtronic, Inc.; Abbott Laboratories (formerly St. Jude Medical, Inc); Royal Philips NV (formerly Volcano Corporation); Arbor Pharmaceuticals, LLC; AstraZeneca Pharmaceuticals, LP; Merck Sharp & Dohme Corp.; Omron Healthcare, Inc, Sunovion Pharmaceuticals, Inc. Espero BioPharma; and Amgen, Inc; and financial donations from Arbor Pharmaceuticals LLC and AstraZeneca Pharmaceuticals LP.

Disclaimer:

This article refers to work supported by National Heart, Lung, and Blood Institute grant U01HL105907, U01HL105462, U01HL105561, U01HL105565; device donations from Abbott Vascular; Medtronic, Inc.; St. Jude Medical, Inc.; Volcano Corporation; and Omron Healthcare, Inc.; medications provided by Amgen Inc; Arbor Pharmaceuticals, LLC; AstraZeneca Pharmaceuticals, LP; Merck Sharp & Dohme Corp.; and by financial donations from Arbor Pharmaceuticals LLC and AstraZeneca Pharmaceuticals LP. The content of this manuscript is solely the responsibility of the authors and does not necessarily reflect the views of the National Heart, Lung, and Blood Institute, the National Institutes of Health, or the United States Department of Health and Human Services.

This project was supported in part by Clinical Translational Science Award Nos. 11UL1 TR001445 and UL1 TR002243 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences, the National Heart, Lung, and Blood Institute, the National Institutes of Health, or the Department of Health and Human Services.

Abbreviations

CAD

coronary artery disease

CCTA

computed coronary tomographic angiography

ECG

electrocardiography

ETT

exercise tolerance test

ISCHEMIA

International Study of Comparative Health Effectiveness With Medical and Invasive Approaches

LAD

left anterior descending coronary artery

LCX

left circumflex coronary artery

LMD

left main coronary artery disease with ≥50% diameter stenosis SPECT = single photon emission computed tomography

I. ISCHEMIA Committee, CCC, Trial-Related Personnel

Past and Current Committee Members

Leadership Committee

Judith S. Hochman (Chair)

David J. Maron (Co-Chair)

William Boden (Co-Principal Investigator)

Bruce Ferguson (Co-Principal Investigator)

Robert Harrington (Co-Principal Investigator)

Gregg W. Stone (Co-Principal Investigator)

David Williams (Co-Principal Investigator)

Executive Committee

Judith S. Hochman (Chair)

David J. Maron (Co-Chair)

Karen P. Alexander

Sripal Bangalore

Jeffrey Berger

William Boden

Robert Harrington

Daniel Mark

Sean M. O'Brien

Harmony R. Reynolds

Yves Rosenberg

Leslee J. Shaw

John Spertus

Gregg W. Stone

Steering Committee

Judith S. Hochman (Chair)

David J. Maron (Co-Chair)

Members of Executive Committee

Christie Ballantyne*

Daniel Berman

Rafael Beyar*

Balram Bhargava

Chris Buller*

Antonio (Tony) Carvalho**

Bernard R. Chaitman

Rafael Diaz*

Rolf Doerr

Vladimir Dzavik

Bruce Ferguson

Shaun Goodman

Gilbert Gosselin

Rory Hachamovitch*

Christian Hamm*

Claes Held

Malte Helm*

Kurt Huber*

Lixin Jiang

Matyas Keltai

Shun Kohsaka

Irene Lang*

Renato Lopes

Jose Lopez-Sendon

Aldo Maggioni

John Mancini

C. Noel Bairey Merz

James Min

Eric Peterson*

Michael H. Picard

Witold Ruzyllo

Joseph Selvanayagam

Roxy Senior

Tali Sharir

Gabriel Steg

Hanna Szwed

Frans Van de Werf*

William Weintraub

Harvey White

David Williams

Optimal Medical Therapy Committee

William Boden (Co-Chair)

David J. Maron (Co-Chair)

Christie Ballantyne

Sripal Bangalore

Karen Calfas **

Bernard R. Chaitman

Mary Ann Champagne

Michael Davidson

Jerome Fleg

Peter A. McCullough

Jonathan Newman

Peter Stone

Optimal Revascularization Therapy Planning Committee

Gregg W. Stone (Chair)

Subcommittee: CABG

Bruce Ferguson (Co-Chair)

Philippe Menasche (Co-Chair)

Sripal Bangalore

Michael Davidson**

Stephen Fremes

Robert Guyton

Michael Mack

Fred Mohr

Anupama Rao

Joe Sabik

Oz Shapira

David Taggart

James Tatoulis

Subcommittee: PCI

David Williams (Co-Chair)

Sripal Bangalore

Jim Blankenship

Sorin Brener

Chris Buller

Antonio Colombo

Bernard de Bruyne

Philippe Généreux

Robert Harrington

Dean Kereiakes

Thierry Lefevre

Jeffrey Moses

Clinical Events

Endpoint Definition Panel

Bernard R. Chaitman (Chair)

Karen P. Alexander

Judith S. Hochman

Ken Mahaffey

David J. Maron

Gregg W. Stone

Harvey White

Clinical Event Review Committee

Bernard R. Chaitman (Chair)

Salvador Cruz-Flores

Nicholas Danchin

Eli Feen

Mario J. Garcia

Paul Hauptman

Abhay A. Laddu

Eugene Passamani

Ileana L. Pina

Maarten Simoons

Hicham Skali

Kristian Thygesen

David Waters

CEC Administrative Group

Karen P. Alexander

Patricia Endsley*

Gerard Esposito

Jeffrey Kanters

John Pownall

Dimitrios Stournaras

ISCHEMIA Imaging Committee

Leslee J. Shaw (Chair)

Daniel Berman

Matthias Friedrich

Rory Hachamovitch

Raymond Kwong

John Mancini

James Min

Dana Oliver

Michael H. Picard

Harmony R. Reynolds

Biostatistics Planning Committee

Frank Harrell (Chair)

Jeffrey Blume

Kerry Lee

Sean M. O'Brien

BioRepository Committee

Jeffrey Berger (Chair)

Claes Held

Iftikhar Kullo

Bruce McManus

Kristin Newby

EQOL Committee

Daniel Mark (Co-Chair)

John Spertus (Co-Chair)

David Cohen

William Weintraub

Recruitment for Women & Minorities

C. Noel Bairey Merz (Chair)

Raffaele Bugiardini

Jelena Celutkiene

Jorge Escobedo

Angela Hoye

Radmila Lyubarova

Deirdre Mattina

Jesus Peteiro

Harmony R. Reynolds

Paola Smanio

Publications

David J. Maron (Chair)

Karen P. Alexander

Sripal Bangalore

Jeffrey Berger

William Boden

Robert Harrington

Judith S. Hochman

Sean M. O'Brien

Harmony R. Reynolds

Yves Rosenberg

Gregg W. Stone

Publication Subcommittees

Economics

Daniel Mark (Chair)

John Spertus

QOL

John Spertus (Chair)

Daniel Mark

Stress Testing

Leslee J. Shaw (Chair)

Dan Berman

Bernard R. Chaitman

Jerome Fleg

Raymond Kwong

Michael H. Picard

Harmony R. Reynolds

Roxy Senior

CCTA

James Min (Chair)

Jonathan Leipsic

John Mancini

Angiography/Optimal Revascularization Therapy

Gregg W. Stone (Chair)

Ziad Ali (Co-chair)

Sripal Bangalore

T. Bruce Ferguson

David Williams

(Philippe Genereux, former Chair, Angiography Subcommittee)*

Optimal Medical Therapy

William Boden (Co-Chair)

David J. Maron (Co-Chair)

Jerome Fleg

Jonathan Newman

Biorepository

Jeffrey Berger (Chair)

Sripal Bangalore

Claes Held

Judith S. Hochman

David J. Maron

Kristin Newby

Jonathan D. Newman

CEC

Bernard R. Chaitman (Chair)

Karen P. Alexander

CKD

Sripal Bangalore (Chair)

Karen P. Alexander

Jerome Fleg

Judith S. Hochman

David J. Maron

Roy Mathew

Sean M. O'Brien

Harmony R. Reynolds

Mandeep Sidhu

CIAO

Harmony R. Reynolds (Chair)

DSMB Members

Lawrence Friedman (Chair)

Jeffrey Anderson

Jessica Berg *

David DeMets

C. Michael Gibson

Gervasio Lamas

Nicole Deming

Jonathan Himmelfarb

Pamela Ouyang

Pamela Woodard

Independent Statistical Analysis Center for DSMB Reporting

Frank Harrell

Samuel Nwosu

NHLBI Program Staff

Project Office

Yves Rosenberg (Project Officer)

Jerome Fleg

Ruth Kirby

Statisticians

Neal Jeffries

ISCHEMIA Clinical Coordinating Center (CCC)

Study Leadership

Judith S. Hochman (Study Chair, Director of CCC)

David J. Maron (Study Co-Chair, Co-Director of CCC, US Country Leader)

CCC Faculty

Sripal Bangalore (Optimal Revascularization Therapy CCC Director, Regional Leader)

Jeffrey Berger (Director of the Biorepository, Regional Leader)

William Boden (US-VA Regional Leader)

Jonathan Newman (Optimal Medical Therapy CCC Director, Regional Leader)

Harmony R. Reynolds (Associate Director of CCC, CCC Imaging Lead, Regional Leader)

Mandeep Sidhu (US-VA Regional Co-Leader)

Program Directors

Jean E. Denaro**

Stephanie Mavromichalis

Project Managers

Kevin Chan

Gia Cobb*

Aira Contreras

Diana Cukali*

Stephanie Ferket*

Andre Gabriel*

Antonietta Hansen*

Arline Roberts

Clinical Research Associates

Michelle Chang

Sharder Islam*

Graceanne Wayser*

Solomon Yakubov*

Michelle Yee

Clinical Trial Assistants

Caroline Callison

Isabelle Hogan

Albertina Qelaj*

Charlotte Pirro*

Kerrie Van Loo

Brianna Wisniewski*

Grants and Finance Administration

Margaret Gilsenan (Grants Manager)

Bevin Lang

Samaa Mohamed

Publications Team

Jihyun Lyo (Publications Manager)

Nadia Gakou

Data Analyst

Vincent Setang*

Mark Xavier*

Statistical and Data Coordinating Center (SDCC)

Sean M. O’Brien (Principal Investigator)

Karen P. Alexander (Co-Principal Investigator)

Akshay Bagai*

Samuel Broderick

Michelle Crowder

Derek Cyr

Patricia Endsley

Jyotsna Garg

Xiangqiong Gu

Robert Harrington*

Lisa Hatch

Anne Heath*

Zhen Huang

Jeffrey Kanters

Kerry Lee*

Jeff Leimberger

Jill Marcus

Courtney Page

Wanda Parker*

Wayne Pennachi

John Pownall

Frank Rockhold

Susanna Stevens

Allegra Stone

Dimitrios Stourna

Omar Thompson

Sheri Ussery

Jennifer White*

Mary (Kaye) Williams

Weibing Xing

Songlin Zhu

Economics and Quality of Life Coordinating Center (EQOL CC)

Duke Clinical Research Institute, Durham, NC

Daniel B. Mark (Principal Investigator)

Kevin Anstrom

Khaula Baloch

Janet Blount

Patricia Cowper

Linda Davidson-Ray

Laura Drew

Tina Harding

J David Knight

Diane Minshall Liu

Betsy O’Neal

Thomas Redick

Saint Luke’s Mid America Heart Institute, Kansas City, MO

John Spertus (Principal Investigator)

Philip Jones

Karen Nugent

Grace Jingyan Wang

ISCHEMIA Imaging Coordinating Center (ICC)

Leslee J. Shaw (Principal Investigator)

Lawrence Phillips

Abhinav Goyal

Holly Hetrick

Dana Oliver

Nuclear Core Lab

Daniel Berman (Director)

Sean W. Hayes (Co-Director)

John D. Friedman

R. James Gerlach

Mark Hyun

Romalisa Miranda-Peats

Piotr Slomka

Louise Thomson

CMR Core Lab

Raymond Y. Kwong (Director)

Matthias Friedrich (Director)*

Francois Pierre Mongeon (Co-Director)

Steven Michael

Echo Core Lab

Michael H. Picard (Director)

Judy Hung

Marielle Scherrer-Crosbie

Xin Zeng

ECG/ETT CoreLab

Bernard R. Chaitman (Director)

Jane Eckstein

Bandula Guruge

Mary Streif

Angiographic Core Lab

Ziad Ali (Director)

Philippe Genereux (Director)*

Maria A. Alfonso

Maria P. Corral

Javier J. Garcia

Jennifer Horst

Ivana Jankovic

Maayan Konigstein

Mitchel B. Lustre*

Yolayfi Peralta

Raquel Sanchez

CCTA Core Lab

James Min (Director)

Reza Arsanjani

Matthew Budoff

Kimberly Elmore

Millie Gomez

Cameron Hague

Niree Hindoyan

Jonathan Leipsic

GB John Mancini

Rine Nakanishi

M. Barbara Srichai-Parsia

Eunice Yeoh

Tricia Youn

Academic Research Organizations (AROs)

Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) -Italy & Switzerland

Aldo P. Maggioni (Country Leader)

Francesca Bianchini

Martina Ceseri

Andrea Lorimer

Marco Magnoni

Francesco Orso

Laura Sarti

Martinia Tricoli*

Brazilian Clinical Research Institute (BCRI) - Brazil

Antonio Carvalho (Country Leader)**

Renato Lopes (Country Leader)

Lilian Mazza Barbosa

Tauane Bello Duarte

Tamara Colaiácovo Soares

Julia de Aveiro Morata

Pedro Carvalho

Natalia de Carvalho Maffei

Flávia Egydio*

Anelise Kawakami*

Janaina Oliveira*

Elissa Restelli Piloto*

Jaqueline Pozzibon*

Canadian Heart Research Centre (CHRC) - Canada

Shaun Goodman (Country Leader)

Diane Camara

Neamat Mowafy

Caroline Spindler

China Oxford Centre for International Health Research - China

Lixin Jiang (Country Leader)

Hao Dai

Fang Feng

Jia Li

Li Li*

Jiamin Liu

Qiulan Xie

Haibo Zhang

Jianxin Zhang

Lihua Zhang

Liping Zhang

Ning Zhang

Hui Zhong

Estudios Clínicos Latino America (ECLA) - Argentina

Rafael Diaz*

Claudia Escobar

Maria Eugenia Martin*

Andrea Pascual*

Foundation for Biomedical Research of La Paz University Hospital (FIBHULP) - Spain

José Lopez-Sendon (Country Leader)

Paloma Moraga

Victoria Hernandez

Almudena Castro

Maria Posada*

Sara Fernandez

José Luis Narro Villanueva

Rafael Selgas

French Alliance for Cardiovascular Trials (FACT) - France

Gabriel Steg (Country Leader)

Helene Abergel

Jean Michel Juliard

Green Lane Coordinating Centre Ltd. (GLCC) -Malaysia, New Zealand, Singapore, Taiwan, Thailand

Harvey White (Country Leader)

Caroline Alsweiler

KU Leuven Research & Development - Belgium*

Frans Van de Werf (Country Leader)

Kathleen Claes

Kaatje Goetschalckx

Ann Luyten

Valerie Robesyn

South Australian Health and Medical Research Institute Ltd (SAHMRI) - Australia

Joseph B. Selvanayagam (Country Leader)

Deirdre Murphy

Contract Research Organizations (CROs) for ISCHEMIA Trial

FOCUS Clinical Research Center d.o.o. Belgrade - Serbia

Nevena Garcevic

Jelena Stojkovic

iProcess Global Research Inc. - India

Asker Ahmed

Richa Bhatt

Nitika Chadha*

Vijay Kumar*

Sadath Lubna*

Pushpa Naik

Shruti Pandey*

Karthik Ramasamy*

Mohammed Saleem

Pratiksha Sharma

Hemalata Siddaram*

II. Site Personnel

Country (No.Randomizations) Investigator(s) Study Coordinator(s) City & State (if applicable) Institution (No. Randomizations)
*United States (853)
Country Leader
David J. Maron, MD
Regional Leader for VA Sites
William E. Boden, MD
Kreton Mavromatis, MD John Doan, MD Decatur, GA Atlanta VA Medical
Jason Linefsky, MD Raven Lee, CCRP
Risha Patel
So Yang Cho
Center (139)
Todd D. Miller, MD Susan Milbrandt
Dawn Shelstad
Rochester, MN Mayo Clinic (50)
Preeti Kamath, BDS, V.A. North Texas
Subhash Banerjee, MD MHA, CCRP
Ishita Tejani, BDS, MS, MSPH
Dallas, TX Health Care System (35)
Harmony R. Reynolds, MD Stanley E. Cobos, BA
Jonathan D. Newman, MD, MPH
Sripal Bangalore, MD, MHA
Kirsten J. Quiles, MS

Raven R. Dwyer, MPH
NYU Langone
Robert M. Donnino, MD
Lawrence M. Phillips, MD
Muhamed Saric, MD, PhD
Dalisa Espinosa, MBS New York, NY Medical Center-Bellevue Hospital (26)
Khaled Abdul-Nour, MD Allison Schley, BS

Heather Golden
Detroit, MI Henry Ford Health System (21)
Peter H. Stone, MD Hermine Osseni, MS
Charlene Wiyarand Peter Douglass, BA
Hayley Pomeroy, BA
Alexandra Craft, BA
Bethany Harvey, BA
Boston, MA Brigham & Women’s Hospital, Harvard Medical School (21)
James J. Jang, MD
Gennie Yee, MD
Olivia Anaya
Phoebe Goold, RN
Steven Giovannone
San Jose, CA Kaiser Permanente San Jose (18)
Cardiology
Steven Weitz, MD Lori Pritchard, RN Schenectady, NY
Associates of Schenectady P.C. (17)
Suzanne Arnold, MD Rosann Gans, RN
James Henry O’Keefe, Jr, MD (PI from 2012–2016) Paul Kennedy, RN Kansas City, MO Saint Luke’s Hospital (17)
Shobana Ganesan, PhD
Michael D. Shapiro, DO David Schlichting, LPN
Aynun Naher
Portland, OR Oregon Health & Science University (17)
Mohammad El-Hajjar, MD
Mandeep S. Sidhu, MD, MBA
Steven A. Fein, MD Wendy L. Stewart, MS
Mikhail T. Torosoff, MD, PhD Kristin M. Salmi, BS Albany, NY Albany Medical Center Hospital (16)
Radmila Lyubarova, MD
Sulagna Mookherjee, MD
Krzysztof Drzymalski, MD
Edward O. McFalls, MD, PhD
Santiago A. Garcia, MD
Stefan C. Bertog, MD Debra K. Johnson, RN Minneapolis, MN Minneapolis VAMC (15)
Rizwan A. Siddiqui, MD Rebekah R. Herrmann, RN
Areef Ishani, MD
Ronnell A. Hansen, MD
Michel Georges Khouri, MD Kristine Arges
Melissa LeFevre
Jennifer Tomfohr
Durham, NC Duke University Medical Center (15)
Kimberly Ann Byrne Louis Stokes
Jonathan L. Goldberg, MS, MD Taissa Zappernick Cleveland, OH Cleveland Veterans Affairs Medical Center (14)
Richard Goldweit, MD Sallie Canada
Meghana Kakade
Patricia Mieses
Stanley E. Cobos, BA
Raven R. Dwyer, MPH
Englewood, NJ Englewood Hospital and Medical Center (13)
Ronny A. Cohen, MD Dalisa Espinosa, MBS
Brooks Mirrer, MD Kirsten J. Quiles, MS Brooklyn, NY NYU-HHC Woodhull Hospital (12)
Victor Navarro, MD Magdalena Rantinella, BS
Jessica Rodriguez, BS
Olivia Mancilla, BS
David E. Winchester, MD, MS Susan Stinson, RN Gainesville, FL Malcom Randall VAMC (11)
Marvin Kronenberg, MD Terry Weyand
Philip Rogal, MD
Christopher McFarren, MD
Sherron C. Crook Nashville, TN Vanderbilt University Medical Center (11)
John F. Heitner, MD Jean Ho
Saadat Khan
Mahmoud Mohamed
Mary R. Soltau, RN
Delsa K. Rose, RN
Brooklyn, NY New York - Presbyterian/Brookly n Methodist Hospital (10)
Ira M. Dauber, MD Rebecca J. Wimmer, RN
Kathy E. Siegel, RN
Susan Derbyshire
Littleton, CO South Denver Cardiology Associates, P.C. (10)
Charles Cannan, MD Michelle Dixon
Gerald Leonard
Ciarra Heard, LVN
Portland, OR Providence Heart and Vascular Institute (10)
Sriram Sudarshan, MD Viviana Gabriel, LVN
Sukie Desire
Wichita Falls, TX Wichita Falls Heart Clinic (9)
Puja K. Mehta, MD
Michael McDaniel, MD
Fauzia Rashid, PhD
Stamatios Lerakis, MD Senait Asier
Atlanta, GA Emory University (9)
Arshed Quyyumi, MD Keyur Patel
Nanette K. Wenger, MD
Chester M. Hedgepeth, MD, PhD Jennifer Gillis, APRN
Heather Hurlburt, MD Megan Manocchia, RN Warwick, RI Kent Hospital (9)
Alan Rosen, MD Susan Moore, RN
Elizabeth Congdon
Gail Brandt
Zakir Sahul, MD Nora Marchelletta
Kristina Wippler
Ypsilanti, MI Michigan Heart, PC (9)
David Booth, MD Yvonne Taul, RN
Steve Leung, MD Jennifer Isaacs, MS
Ahmed Abdel-Latif, MD, PhD Viktoria Bulkley, RN Lexington, KY University of Kentucky (8)
Hassan Reda, MD Caroline Rodgers
Khaled Ziada, MD
Sampoornima Kimberly E. Halverson, RHIT La Crosse, WI Gundersen Lutheran
Setty, MD Christine Roraff, RN
Jonean Thorsen, RN
Medical Center (8)
Rajat S. Barua, MD, PhD Amarachi Ojajuni
Oni Olurinde
Kamalakar Surineni
Kansas City, MO Kansas City VA Medical Center (8)
Fadi Hage, MD
Christiano Caldeira, MD
James E. Davies, MD
Massoud Leesar, MD
Jaekyeong Heo, MD
Amy Iskandrian, MD
Firas Al Solaiman, MD
Satinder Singh, MD
Badhma Valaiyapathi, MD Birmingham, AL UAB Vascular Biology and Hypertension Program (8)
Khaled Dajani, MD Carol M. Kartje, BSN Maywood, IL Loyola University Medical Center (8)
Mohammad El-Hajjar, MD
Paul Der Mesropian, MD
Joseph Sacco, MD
Michele Rawlins, NP Samuel Stratton VA
Brian McCandless, MD
Marisa Orgera, MD
Jennifer Thomson, MA Albany, NY Medical Center of Albany NY (7)
Mandeep S. Sidhu, MD, MBA (2012–2016)
Mary Colleen Rogge, RN
Imran Arif, MD Julie Bunke, BA
Hanan Kerr, MD Kendra Unterbrink, PA
Jacqueline Fannon, RN
Cynthia Burman, NP
Cincinnati, OH Cincinnati VA Medical Center (7)
Jorge F. Trejo (Gutierrez), MD
Gerald Fletcher, MD
Gary E. Lane, MD
Lynn M. Neeson, DNP
Pragnesh P. Parikh, MD
Peter M. Pollak, MD
Marcia F. Dubin, CCRP Jacksonville, FL Mayo Clinic Florida (7)
Brian P. Shapiro, MD
Kevin Landolfo, MD
Anthony Gemignani, MD Sarah Beaudry, RN White River VAMC-White River
Daniel O’Rourke, MD Junction, VT Junction (7)
Judith L. Meadows, MD Stephanie A. Tirado, RN West Haven, CT VA Connecticut
Janet Halliday
Pamela Julian Stephanie, M. Lane,
Healthcare System (7)
Winchester
Jason T. Call, MD RN, BSN, CCRN
Jennifer L. Stanford, RN, MSN
Winchester, VA Cardiology and Vascular Medicine, PC (7)
Joseph Hannan, MD Saint Vincent
Robert Bojar, MD
Deepti Kumar, MD
John Mukai, MD
Patricia Arsenault, RN
Pamela Sigel, RN
Worcester, MA Hospital at Worcester Medical Center (7)
Edward T. Martin, MS, MD Miriam Brooks Tulsa, OK Oklahoma Heart Institute (7)
Gabriel Vorobiof, MD Ladda Douangvila Los Angeles, CA Ronald Reagan
Rubine Gevorgyan
Fatima Ranjbaran, RN
UCLA Medical Center (7)
Alec Moorman, MD Bryn Smith, BS
Carly Ohmart
Seattle, WA University of Washington Medical Center (7)
Scott Kinlay, MBBS, PhD
Robert J. Hamburger, MD
Thomas P. Rocco, MD
Samantha Ly, MA
Deepak L. Bhatt, MD, MPH
Kevin Croce, MD, PhD
Margot C. Quinn, BA
Sara Temiyasathit, PhD
West Roxbury, MA VA Boston Healthcare System (6)
Jacquelyn A Quin, MD Jacquelyn Do, MPH
Jati Anumpa, MD
Marco Zenati, MD, MSc
David P Faxon, MD
Desiree Tobin, MPH
Glenn Rayos, MD Jennifer Langdon

Marcia Werner Bayer
Daytona Beach, FL Daytona Heart Group (6)
Ashraf Seedhom, MD
Lance Sullenberger, MD
Amanda O’Malley
Erin Orvis
Albany, NY Capital Cardiology Associates (6)
Mandy Murphy, RN Bethesda, MD
Gregory Ann Greenberg, RN NIH Heart Center at
Kumkumian, MD
Steven P. Sedlis, MD
Margaret Iraola, RN Suburban Hospital (6)
Leandro C.Maranan, VA New York Harbor
Robert M. Donnino, MD
Jeffrey Lorin, MD
CCRC New York, NY Health Care System (6)
Jacqueline E. Tamis-Holland, MD
Robert Kornberg, MD
Ammy Malinay, RN Ridgewood, NJ Mount Sinai Saint Luke’s Hospital (6)
Robert Leber, MD
Souheil Saba, MD
Michael W. Lee, MD
Delano R. Small, MD
Wassim Nona, MD
Patrick B. Alexander, MD
Candice P. Edillo, RN Southfield, MI Providence - Providence Park Hospital (6)
Iram Rehman, MD
Ann Ostrander, RN
Umesh Badami, MD Stephanie Wasmiller, RN Saginaw, MI Covenant Medical Center, Inc. (5)
Kevin Marzo, MD Wendy Drewes, RN
Dipti Patel, RN
Mineola, NY NYU Winthrop (5)
Inga H. Robbins, MD
Howard A. Levite, MD Jackie M White, RN, BSN CCRC Pomona, NJ AtlantiCare Regional Medical Center (5)
Sanjay Shetty, MD
Mayuri Patel, MD
Alison Hallam
Glenn S. Hamroff, MD Benjamin J Spooner, RPA-C Cortlandt NYP Medical Medical Group Hudson Valley
Linda M Hollenweger, LPN,CCRC Manor, NY Cardiology (5)
Raymond W. Little, MD
Brandi D. Zimbelman, FNP-C Charles Y. Lui, MD
Holly Little

Tiffany Little
Houston, TX Houston Heart & Vascular Associates (5)
Brigham R. Smith, MD
Daniel P. Vezina, MD, MSC
Lillian L. Khor, MBBCh, MSc
Josephine D. Abraham, MD, MPH
David A. Bull, MD
Stephen H.
McKellar, MD, MSc Nona A Eskelson, RN

Salt Lake City,
Salt Lake City VA Medical Center (4)
David Booth, MD
John Kotter, MD
Yvonne Taul, RN
Caroline Rodgers, RN
Ahmed Abdel-Latif, MD, PhD Jennifer Isaacs, MS Lexington, KY Lexington VA Medical Center (4)
Viktoria Bulkley
Bob Hu, MD Renee Kaneshiro Palo Alto, CA Palo Alto Medical Foundation Research Institute (4)
Arthur J. Labovitz, MD
Michael Berlowitz, MD
Bonnie J. Kirby, RN, MSN
Philip Rogal, MD Nhi N. Tran, MS University of South

Florida (4)
Christopher McFarren, MD
Fadi Matar, MD
Catherine Jahrsdorfer, RN, BSN Tampa, FL
Christiano Caldeira, MD
David J. Maron, MD
Fatima Rodriguez, MD, MPH Reem Yunis, PhD
Ingela Schnittger, MD
William F. Fearon, MD
Jhina Patro Stanford, CA Stanford University School of Medicine (4)
Prakash UCSF - Fresno
Deedwania, MD
Kiran Reddy, MD
Antonia Vega Fresno, CA Community Regional Medical Center (4)
Hugo Bloise-Adames
Joseph Sweeny, MD Santa Jimenez
Nicole Saint Vrestil
Reyna Bhandari
New York, NY Icahn School of Medicine at Mount Sinai (4)
Christopher Spizzieri, MD Danielle Schade
Roxanne Yost
Camp Hill, PA Holy Spirit Hospital Cardiovascular Institute (4)
Claudia P Hochberg, MD Paula Beardsley Boston, MA Boston Medical Center (4)
Denise Fine Jana Tancredi, RN, MA/MSN, CCRN
William D. Salerno, MD Patricia Arakelian
Susan Mathus
Saddle Brook, NJ Hackensack University Medical Center (4)
Deborah O’Neill
Joy Burkhardt, CCRP
Ray Wyman, MD Suellen Hosino, RN, BSN, CCRP Torrance, CA Torrance Memorial Medical Center (4)
Oksana A. Lubyanaya, BA
se D. Salas, BS
Santa Ana, CA
Coastal Heart Medical Group (4)
Amer Zarka, MD
Anil V. Shah, MD
Maria Aguirre
Manu Dhawan
Diana Parra
Tri Tran
Catherine Weick, BSRT(R)(VI)
Katie Fowler-Lehman, BSN
Thomas Haldis, DO Natalie Spitzer, BSN
Casey Riedberger
Catherine Weick
Fargo, ND Sanford Health (4)
Stanley E. Cobos, BA
Raven R. Dwyer, MPH
NYU New York
Jeffrey A. Kohn, MD Dalisa Espinosa, MBS
Kirsten J. Quiles, MS
Carrie Drum, RN
New York, NY Medical Associates (4)
Saket Girotra, MD Kimberly Miller-Cox, RN
Amy Ollinger, RN
Elizabeth Capasso-Gulve
Iowa City, IA University of Iowa Hospitals and Clinics (4)
Omar Almousalli, MD Alaine Melanie Loehr
Marlowe Mosley
Fairview

Heights, IL
Advanced Heart Care Group (4)
Mayil S. Krishnam, MD Shirin Heydari, MS
Jeffrey C. Milliken, MD Andrea M. Lundeen, MA
Pranav M. Patel, MD Edgar Karanjah, MD
Arnold H. Seto, MD
Kevin T. Harley, MD
Wanda C. Marfori, MD
Eduardo Hernandez-Rangel, MD
Orange, CA University of California Irvine Medical Center (3)
Michael A. Gibson, MD
Byron J. Allen, MD
Pam Singh
Rita Coram, MD Anne Marie Webb, BSN Louisville, KY University of Louisville (3)
Ellie Fridell, BS
Heidi Wilson, BS
Sabu Thomas, MD, MSc Angela Kim, BS
Ronald G Schwartz, MD, MS
Wei Chen, MD, MS
Patrick Wilmot, BS Rochester, NY University of Rochester (3)
Mahfouz El Shahawy, MD Ramona Stevens Sarasota, FL Cardiovascular Center of Sarasota (3)
James Stafford, MD Loriane Black Baltimore, MD University of Maryland Medical Center (3)
Amber B. Hull, RN
Olivia J. Lim, RN
Helen C. Tucker
William B. Abernethy, MD Natasha C. Putnam, RN
Linda L. Hall
Tia Cauthren
Trish Tucker
Asheville, NC Asheville Cardiology Associates (3)
Andrew Zurick, MD Hollie Horton

Jan Orga
Nashville, TN Saint Thomas Hospital (3)
Thomas M. Meyer, MD
Ronald G. Morford, MD
Joyce R. White, MSN NP-C
Cynthia Baumann, RN
Lynchburg, VA Stroobants Cardiovascular Center (3)
Bruce Rutkin, MD Vidya Seeratan Manhasset, NY Northwell Health - Manhasset (3)
Sabahat Bokhari, MD Magnolia Jimenez New York, NY Columbia University Medical Center (3)
Seth I. Sokol, MD
Jay Meisner, MD
Cidney Schultz, RN
Jeanne Russo, RN
Bronx, NY Jacobi Medical Center (3)
Ihab Hamzeh, MD
Arunima Misra, MD
Zohra Huda, RN, BSN, CCRP
Matthew Wall Jr., MD
Veronica Lenges De Rosen, MD
Mahboob Alam, MD
Araceli Boan Houston, TX Baylor College of Medicine (3)
Michael C. Turner, MD

Thomas J. Mulhearn, MD
Christine R Hinton Lake Charles, Cardiovascular Specialists of Southwest Louisiana (3)
Beth A. Archer, BSN, RN
Julia S. Dionne, BA
LA
Arnold P. Good, MD Cheryl A. Allardyce, BSN, RN
Lindsey N. Sikora, BSN, RN
Jennifer H. Czerniak, RN
Columbus, OH Ohio Health Grant Medical Center (3)
Jennifer A. Mull, MSN, RN
Elizabeth Ferguson
Frances Laube
Gail A Shammas, BSN, RN Midwest
Nicolas W. Shammas, MD, MS Lori Christensen Holly Park Davenport, IA Cardiovascular Research Foundation (3)
Robert Chilton, MD Joan Hecht San Antonio, TX Audie Murphy V.A. (2)
Patricia K. Nguyen, MD Davis Vo, BS
James Hirsch
Palo Alto, CA VA Palo Alto Healthcare System (2)
Matthew Jezior, MD Jody Bindeman Sara Salkind
Dalisa Espinosa, MBS
Lori-Ann Desimone, BSN
Palo Alto, CA Bethesda, MD VA Palo Alto Healthcare System (2)
Walter Reed National Military Medical Center (2)
Paul C. Gordon, MD
Thomas Crain, MD
Lina Felix-Stern
Jassira Gomes
Catherine Gordon, BSN
Providence, RI Miriam Hospital (2)
Robert Stenberg, MD Aimee Mann Johnstown, PA Conemaugh Valley Memorial Hospital (2)
Ronald P. Pedalino, MD Theresa McCreary
Stanley E. Cobos, BA
Raven R. Dwyer, MPH
Dalisa Espinosa, MBS
Kirsten J. Quiles, MS
Stanley E. Cobos, BA
Brooklyn, NY NYU-HHC Kings County Hospital Center (2)
New York University - Langone
Joseph Wiesel, MD Raven R. Dwyer, MPH
Dalisa Espinosa, MBS
Kirsten J. Quiles, MS
Candace Gopaul, BS
Flushing, NY Cardiovascular Associates (2)
George J. Juang, MD Karen Hultberg
Tauqir Huk
Afshan Hussain
Yesenia Zambrano, BS
Brooklyn, NY Coney Island Hospital (2)
Mohammed Al-Amoodi, MD Sarah Medina
Rodriguez Trudie Milner Abbey Mulder, RN
Yuma, AZ Yuma Regional Medical Center (2)
David Wohns, MD Stacie Van
Oosterhout, MEd
Grand Rapids, MI Spectrum Health (2)
Ellis W. Lader, MD Martha Meyer, RN, MSN
Nancy L. Clapp, RN, BA, CCRC
Kingston, NY Mid Valley Cardiology (1)
Michael Mumma, MD Heather Barrentine Jenne M. Jose, PA Sarasota, FL Sarasota Memorial Hospital (1)
Lekshmi Dharmarajan, MD Stanley E. Cobos, BA
Raven R. Dwyer, MPH
Dalisa Espinosa, MBS
Kirsten J. Quiles, MS
Jenne Manchery Bronx, NY
NYU-HHC Lincoln Medical and Mental Health Center (1)
Joseph F.X. McGarvey Jr, MD
Thomas R. Downes, MD (till Dec. 2016)
Vera McKinney, RN
Linda Schwarz, RN
Scott M. Kaczkowski
Doylestown, PA Doylestown Health Cardiology (1)
Gary J. Luckasen, MD (from Dec. 2016) Adam J. Jaskowiak Joel Klitch Loveland, CO Medical Center of the Rockies (1)
Joel Klitch
Benjamin Cheong, MD
Srinivasa Potluri, MD
Debra Dees
Precilia Vasquez
Houston, TX
Plano, TX
Baylor St. Luke’s Medical Center (1)
Baylor Research Institute at Legacy Heart Center (1) **
Ronald A. Mastouri, MD
Jeffery A. Breall, MD, PhD
George E. Revtyak, MD
Jonathan W. Bazeley, MD
Elise L. Hannemann, RN,CCRC
Judy Mae Foltz, RN,CCRC
Indianapolis, IN Indiana University/Krannert Institute of Cardiology (1)
Emily DeRosa
Dayuan Li, MD Beth Jorgenson
Joyce Riestenberg-Smith
St. Paul, MN HealthEast Saint Joseph’s Hospital (1)
Kenneth Giedd, MD New York, NY Beth Israel Medical Center (1)
Wayne Old, MD

Francis Burt, MD
Rebecca Bariciano Chesapeake, VA
Bethlehem, PA
Cardiovascular Associates, Ltd. (1)
Saint Luke’s Hospital and Health Network (1)
Kozhaya Sokhon, MD Jessica Waldron Sugar land, TX Medicus Alliance
Michelle Mayon Clinical Research Org., Inc. (1)
Deepika Gopal, MD Plano, TX The Heart Hospital Baylor (1)
Uma S. Valeti, MD Gretchen Ann Peichel, RN
Brandy Starks
Minneapolis, MN University of Minnesota (1)
Jon Kobashigawa, MD Rajesh Gopalan Nair, MD, DNB, DM Lucilla Garcia Maria Thottam
India (941)
Country Leader
Balram Bhargava, DM Anjali Anand, MSc
Sajeev Chakanalil
Govindan, MD, DNB, DM, PhD
Janitha Raj, B.Tech

Reshma Ravindran, MSc
Beverly Hills, Cedars Sinai Medical CA Center (1)
Calicut Government Medical College (208)
Rajalekshmi VS, MSc, MScCRRA
Cholenahally Nanjappa Manjunath, MD, DM

Nagaraja Moorthy, MD, DM
Nandita Nataraj, BE(Biotech) PGDICRCDM
Soundarya Nayak, BE(Biotech) PGDICRCDM
Satvic Cholenahally Manjunath, MD,DM Mahevamma Mylarappa, GNM (General Nursing) Bangalore Sri Jayadeva Institute of Cardiovascular Sciences and Research (149)
Suryaprakash Narayanappa, MBBS
Neeraj Pandit, MD, DM
Sheromani Bajaj
Ranjit Kumar Nath, MD, DM Vandana Yadav, Msc,PGDACR
Girish Mishra, Msc, PGDACR
New Delhi Dr Ram Manohar Lohia Hospital (101)
S.K. Dwivedi, DM
V.S. Narain, DM
Roma Tewari, PG
Meenakshi Mishra, PG
King George’s
Sharad Chandra, DM Shivali Patel

Suman Singh, PG
Lucknow Medical University, Department of Cardiology (100)
Gurpreet S. Wander, DM
Rohit Tandon MD
Sarju Ralhan, M.Ch (CTVS) Baljeet Kaur, MSc (Biotechnology) Ludhiana Hero DMC Heart Institute, Dayanand Medical College and
Naved Aslam, DM Sonika Gupta, MBA, B. Pharmacy Hospital (83)
Abhishek Goyal, DM
Balram Bhargava, DM
G.Karthikeyan, DM
S.Ramakrishnan, DM
Sandeep Seth, DM
Rakesh Yadav, DM
Sandeep Singh, DM
Ambuj Roy, DM
Neeraj Parakh, DM
Chandini Suvarna, BDS New Delhi All India Institute Of Medical Sciences (67)
Sunil Kumar Verma, DM
Rajiv Narang, DM
Sundeep Mishra, DM
Nitish Naik, DM
Gautam Sharma, DM
Shiv Kumar Choudhary, M.Ch Chetan Patel, DNB
Gurpreet Gulati, MD
Sanjeev Sharma, MD
V K Bahl, DM
Anoop Mathew, MD Binoy MOSC Medical
Eapen Punnoose, MD Mannekkattukudy Kurian Kolenchery College Hospital (39)
Milind Avdhoot Gadkari, MD Sheetal Rupesh Karwa, BHMS
Siddharth Gadage, MD DNB
Tapan Umesh Pillay, BHMS MSc
Suvarna Kolhe, MSc Pune KEM Hospital Pune (35)
Santhosh Satheesh, MBBS, MD, DM R. J. Vindhya, B.Sc. (Bio-Technology),
MSc(Bio-Informatics)
Pondicherry Jawaharlal Institute of Postgraduate Medical
Education & Research (JIPMER) (31)
Peeyush Jain, MD
Ashok Seth, MD
Zile Singh Meharwal, MD
Atul Mathur, MD
Upendra Kaul, MD
Atul Verma, MD
Mona Bhatia, MD
Ankush Sachdeva, MD
Thounaojam Indira Devi, RN
Nungshi Jungla, RN
New Delhi Fortis Escort Heart Institute (31)
Johann Christopher, MD, DNB K. Manjula Rani, MSc.
Rajeev Menon, MD, DNB M. Sowjanya Reddy, BSc Hyderabad Gurunanak CARE Hospital (27)
Nirmal Kumar, MD, DNB K. Preethi, BSc
Abraham Oomman, MD,DM,DNB Rinu R sidh, MSc(Clinical Research)
Robert Mao, MD, DM Ramakrishnan T., B.Tech(Biotechnology) Chennai Apollo Research and Innovation (23)
Hilda Solomon, PhD Rajesh Francis, MSc(Clinical Research)
Sudhir Naik, MD, DM
Sajeeda Parveen Khan, MBBS, (Dip.Card) Vamshi Priya P., MSc Hyderabad Apollo Research & Innovations (13)
Johann Christopher, MD
Nirmal Kumar, MD
Kotiboinna Preethi Hyderabad CARE Nampally (11)
Purvez Grant, MD Shweta Hande, BHMS, PGDCR
Poonam Sonawane, B.ScMicrobiology, ACCR
Pune Ruby Hall Clinic,Grant Medical Foundation (10)
Ranjan Kachru, MD Abhishek Dubey
Kavita Rawat
New Delhi Fortis Healthcare Fl.t Lt. Rajan Dhall Hospital (4)
Ajit Kumar VK, MD, DM
Sanjay Ganapathi, MD, DM
Jayakumar K, MS, M.Ch Vineeth CP Sree Chitra Tirunal Institute for Medical Sciences and Technology (3)
Harikrishnan Sivadasanpillai, MD, DM Manas Chacko, RN Trivandrum
Bijulal Sasidharan, MD, DM
Kapilamoorthy TR, MD
Suresh Babu
Johann Christopher, MD Sowjanya Reddy
Praneeth Polamuri, MD Manjula Rani Hyderabad CARE Hospital (3)
Priyadarshani Batra Hospital and
Upendra Kaul, MD Arambam Bebek Singh New Delhi Medical Research Centre (BHMRC) (3)
United Kingdom (539)
Country Leaders
Roxy Senior, MBBS, MD, DM
Keith AA Fox, MBChB (past)
Country Coordinators
Grace M. Young, MSc, BSc (Hons)
Kathryn Carruthers (past)
Roxy Senior, MBBS, MD, DM
Ahmed Elghamaz, MB BCh
Sothinathan Gurunathan, MBChB
Harrow Northwick Park Hospital Harrow/ Royal Brompton Hospital London (202)
Nikolaos Karogiannis, MBBS Grace M. Young, MSc, BSc (Hons)
Benoy N Shah, MD, MBBS, BSc (Hons)
Richard HJ Trimlett, MBBS, CCST
Christopher Kinsey

Raisa Kavalakkat, MSc, BSc, RN
Michael B Rubens, LRCP, MRCS, MBBS, DMRD Jo Evans, RN
Edward D Nicol, MD, BMedSci, MBBS, DTM&H
Tarun K Mittal, MD
Ikraam Hassan, RN
Reinette Hampson, BSc (Hons), BA (Hons)
Sarah Williams, RN
Reto Andreas Gamma, MBBS Kim Holland, RN
Karen Swan, RN
Chelmsford Broomfield Hospital (39)
Mark A de Belder, MD Bev Atkinson, RN Middlesbrough The James Cook University Hospital, Middlesbrough (37)
Jeet Thambyrajah, MD
Thuraia Nageh, BSc(Hons) MBBS MD MRCP
John R Davies, MBBS, PhD
Swapna Kunhunny, MRes Clin Res, BSc (N), RN Westcliffe on Sea Southend University Hospital (34)
Steven J. Lindsay, MD Craig Atkinson, RN
John Kurian, MD
Haqeel Jamil, MD
Carita Krannila, RN
Manitha Vinod, RN
Bradford Bradford Royal Infirmary (20)
Osama Raheem, MD
Angela Hoye, MD Lisa Chaytor
Leanne Cox
Julie Morrow
Kay Rowe
Cottingham The University of Hull/Castle Hill Hospital (19)
Patrick Donnelly, MD Stephanie Kelly, RN
Bernardas Valecka, MD Susan Regan, RN Belfast South Eastern Health and Social Care (17)
Dawn Turnbull
Catherine Fleming
Anoop Chauhan, MD Arijit Ghosh
Karen Gratrix
Blackpool Blackpool Teaching Hospitals (16)
Stephen Preston
Craig Barr, MD Anne Cartwright Dudley Russells Hall Hospital (15)
Khaled Alfakih, MBBS, MD
Jonathan Byrne, PhD
Ian Webb, PhD, MA
Abigail Knighton, BSc., PG Dip.
Katherine Martin, RGN, Dip. N, MSc
London King’s College NHS Foundation Hospital (14)
Peter Henriksen, PhD, MB ChB, BSc(Hons) Laura Flint, RGN

James Harrison, BSc(Hons), PG dip
Edinburgh Royal Infirmary of Edinburgh (13)
Peter OKane, MD Nicki Lakeman Bourneouth Royal Bournemouth Hospital (13)
Ramesh de Silva, MB ChB, MD Anja Ljubez Bedford Bedford Hospital NHS Trust (11)
Dwayne S. G. Conway, MD Judith Wright
Donna Exley
Wakefield Pinderfields Hospital (11)
Alexander A Sirker, MB BChir, PhD Mervyn Andiapen, RN
Amy J. Richards, BSc
London University College London Hospitals NHS Foundation Trust

BartsHealth NHS Trust (11)
Stephen P Hoole, MD Lisa Wong, MSc Cambridge Papworth Hospital (10)
Fraser N. Witherow, MD Melanie J. Munro, RGN Dorchester Dorset County Hospital (8)
Nicola Johnston, MB, Bch BAO, MRCP, MD Michelle McEvoy, RN
Mark Harbinson, MB, Bch BAO, MRCP, MD
Simon Walsh, MB, Bch BAO, MD
Caroline Brown, RN Belfast Belfast Trust (7)
Hanna Douglas, MB, Bch BAO, MRCP, MD
Thabitha Charles Central Manchester
Matthew Luckie, MD Laurel Kolakaluri
Hannah Phillips
Louise Morby, RN
Manchester University Hospital (7)
Jolanta Sobolewska, MD Karen Hallett, RN
Carolyn Corbett, RN
Lynne Winstanley
Oldham The Pennine Acute Hospitals NHS Trust (6)
Paramjit Jeetley, MD Royal Free London
Niket Patel, MD
Tushar Kotecha, MBChB, Mpharm Christopher Travill, MBBS, MD
Iqbal Karimullah,
MBBS Angelique Smit, RN

London Susan Gent, SRN
RGN Nafisa Hussain, BSc Luton NHS Foundation T rust (6)
Luton and Dunstable University Hospital NHS FT (5)
Mahmud Al-Bustami, MBBS
Denise Braganza, MD Fiona Haines Peterborough Peterborough City Hospital (5)
Robert Henderson, MD Joanne Taaffe
Jane Burton
Kate Pointon, MBBS Maria Colton Nottingham Nottingham University Hospitals (4)
Surendra Naik, PhD
Thomas Mathew, MBBS, MD, DM
Rachel King
Ammani Brown, MSc BA RN
Andrew Docherty, RN
Colin Berry, BSc MB ChB, PhD
Damien Collison, MB ChB
Giles Roditi, MB ChB
Lisa McCloy, RN

Kate Robb, RN

Craig Paterson, PhD
Clydebank University of Glasgow (4)
Wenda Crawford, RN
Joanne Kelly, RN
Lorraine McGregor, RN
Andrew J Moriarty, BSc MB PhD Anne Mackin, RN, BSc Craigavon Cardiovascular Research Unit, Craigavon Area Hospital (2)
Jason D. Glover, MBBS
Jiwan Pradhan, MBBS
Janet P Knight, RN Basingstoke Hampshire Hospitals NHS Foundation Trust (2)
Ghada Mikhail, MD Imperial College
Darrel P. Francis, MD, MA Tuhina Bose London IHealthcare NHS Trust (1)
*Canada (447)
Country Leaders
Vladimir Dzavik, MD
Shaun G. Goodman, MD, MSc
Gilbert Gosselin, MD
Anna Proietti, RN
Myriam Brousseau, RN
Gilbert Gosselin, MD Magalie Corfias, RN
Patricia Blaise
Luc Harvey
Montreal, QC Montreal Heart Institute (90)
Ariel Diaz, MD
Philippe Rheault, MD
Trois-Rivieres, QC Centre Hospitalier de
Regional Trois-Rivieres (71)
Miguel Barrero, MD Carl-Éric Gagné, MD Patricia Alarie
Yanek Pépin-Dubois, MD Linda Arcand
Ricardo Costa, MD Isabelle Roy
Ying Tung Sia, MD Estelle Montpetit
Catherine Lemay, MD
Alejandro Gisbert, MD
Pierre Gervais, MD
Alain Rheault, MD
Katia Drouin, RN
Denis Carl Phaneuf, MD Christine Bergeron, RN Terrebonne, QC CISSSL - Hopital Pierre-Le Gardeur (42)
Gilbert Gosselin, MD Christine Shelley
Christine Masson Sandy Carr, RN
Pallav Garg, MBBS, MSc Catherine Bone, RN London, ON London Health Sciences Centre (35)
Benjamin J.W. Chow, MD Ermina Moga
Renee C. Hessian, MD Janetta Kourzenkova Ottawa, ON University of Ottawa Heart Institute (29)
Rob S. Beanlands, MD Olga Walter
Richard F. Davies, MD
Kevin R. Bainey, MD, MSc Norma Hogg, RN Suzanne Welsh, RN Edmonton, AB University of Alberta (28)
Asim N. Cheema, MD, PhD
Akshay Bagai, MD, MHS
Ron Wald, MDCM, MPH
Shaun G. Goodman, MD, MSc Khrystyna Kushniriuk, HBSc, MD Toronto, ON St. Michael’s Hospital (27)
John Joseph Graham, MRCP, MB ChB, BSc Mohammed Hussain
Mark Peterson, MD, FRCSC, PhD Olugbenga Bello
Chi-Ming Chow, MD, CM, MSc
Beth Abramson, MD, MSc
Asim Nazir Cheema, MD Ishba Syed, MBBS Mississauga, ON Dixie Medical Group (24)
Mohammad Tariq Vakani, MD Mohammed Hussain, BSc(H)
Khrystyna Kushniriuk, MBBS
Judy Otis, CRC
James Cha, MD Rebecca Otis, CRC Michelle M Seib, RN Oshawa, ON Dr. James Cha (21)
Andrew G Howarth, MD, PhD Sandra M Rivest, RN Calgary, AB University of Calgary (15)
Rosa Sandonato, BSCN
Graham Wong, MD Jackie Chow
Andrew Starovoytov
Naomi Uchida
Ngaire Meadows
Vancouver, BC Vancouver General Hospital (15)
Amar Uxa, MD Nadia Asif
Suzana Tavares
Toronto, ON University Health Network (14)
Paul Galiwango, MD Bev Bozek, RN, CCRC
Saleem Kassam, MD Maria Shier Scarborough, ON Scarborough Cardiology Research (9)
Ashok Mukherjee, MD Lori-Ann Larmand
A. Joseph Ricci, MD Amir Janmohamed
Andy Lam, MD Brenda Hart
Jane Marucci
Sharon Tai
Sonya Brons, RN
Chris Beck, RN
East Grimsby, ON West Lincoln Memorial Hospital (8)
Shamir Mehta, MD Glenda Wong, RN
Krystal Etherington
Hamilton, ON Hamilton General Hospital (7)
Thippeekaa
Arumairajah
Maria Aprile
Jacob Udell, MD Sara Karlsson
Susan Webber
Toronto, ON Women’s College Hospital (7)
Philippe Généreux, MD Chantale Mercure Montréal, QC Centre Intégré Universitaire de Santé et de Services Sociaux du Montréal (2)
Adnan Hameed, MD Nancy Aedy St. Catharines, ON Saint Catharines General Hospital (2)
Fran Farquharson Northwest GTA
Ledjalem Daba, MD Anam Siddiqui Vaughan, ON Cardiovascular and Heart Rhythm Program (1)
Brazil (399)
Country Leaders
Antonio Carlos Carvalho, MD, PhD
Renato D. Lopes, MD, PhD
Whady A. Hueb, MD
Paulo Cury Rezende, MD Myrthes Emy Takiuti, RN Sao Paulo Heart Institute (InCor) University of São Paulo (127)
Expedito Eustáquio Ribeiro Silva, MD
Alexandre Ciappina Hueb, MD
Paola Emanuela Poggio Smanio, MD, PhD
Leonardo Pizzol Caetano, PhD São Paulo Instituto Dante Pazzanese de Cardiologia (98)
Alexandre Schaan de Quadros, MD
Renato Abdala Karam Kalil, MD Aline Peixoto Deiro
José Luiz da Costa Vieira, MD Alice Manica Muller
Gabriel Grossmann, MD Maria Antonieta Pereira de Moraes Bruna Maria Ascoli Porto Alegre Instituto de Cardiologia de Porto Alegre (41)
Pedro Píccaro de Oliveira, MD
Leonardo Bridi, MD Sílvia Zottis Poletti
Simone Savaris, MD
João V Vitola, MD, PhD
Rodrigo J Cerci, MD, Msc Sandra S. Zier, BSc Curitiba Quanta Diagnostico & Terapia (33)
Fabio R Farias, MD, Msc Vilmar Veiga Jr, BSc
Miguel M Fernandes, MD, PhD
José Antonio Marin-Neto, MD, PhD
André Schmidt, MD, PhD Hospital das Clinicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (31)
Moysés de Oliveira Lima Filho, MD, PhD Diego Franca da Cunha Ribeirao Preto
Ricardo Mendes Oliveira, MD
João Reynaldo Abbud Chierice, MD
Carísi A. Polanczyk, MD Guilherme G Rucatti, PsyD Hospital de Clínicas de Porto Alegre (12)
Mariana V. Furtado, MD Fernanda Igansi, BSc Porto Alegre
Luis F. Smidt, MD Mauren P Haeffner, BSc
Antonio Carlos Carvalho, MD Viviane Almeida Sao Paulo Unifesp - Hospital Sao Paulo (9)
Gustavo Pucci, MD Gabriela Sanchez de Souza
Flavio Lyra, MD
Alvaro Rabelo Alves Junior, MD
Mayana Almeida
Viviane dos Santos
Salvador Fundacao Bahiana de Cardilogia (9)
Marianna D. A. Dracoulakis, MD, PhD
Rodolfo G. S. D Lima, MD Natalia S Oliveira, RN Salvador Hospital da Bahia (8)
Estevao Figueiredo, MD Bruna Edilena Paulino Azevedo
Marco Bizzaro Santos
Belo Horizonte Hospital Lifecenter (8)
Paulo Ricardo Caramori, MD Amanda Germann
Vitor Gomes
Rosa Homem
Ellen Magedanz
Porto Alegre Hospital Sao Lucas da Pontificia Universidade Catolica do Rio Grande do Sol (7)
Rogerio Tumelero, MD Rosane Laimer
Alexandre Tognon
Fundo Hospital Sao Vicente de Paulo (5)
Frederico Dall’Orto, MD Pocos de Caldas Hospital Maternidade e Pronto Socorro Santa Lucia (4)
Claudio T. Mesquita, MD
Alexandre S. Colafranseschi, MD
Amarino C. Oliveira Jr., MD Roberta P Santos, RN Botafogo Hospital Pró-Cardiaco (3)
Luiz A. Carvalho, MD
Isabella C. Palazzo, MD
Andre S. Sousa, MD
Expedito Eustáquio Ribeiro da Silva, MD, PhD
Pedro Gabriel Melo de Barros e Silva, MD, PhD Mariana Yumi Okada, RN
Luciana de Pádua Silva Baptista, MD, PhD Ana Paula Batista, RN Sao Paulo Hospital TotalCor (2)
Marcelo Jamus Rodrigues, MD Aline Nogueira Rabaça, BS
Marcos Valério Coimbra de Resende, MD, PhD
Jose Francisco Saraiva, MD Larissa Miranda Trama Sao Paulo Hospital Celso Pierro (1)
Talita Silva
Camila Thais de Souza Ormundo
Carla Vicente
Costantino Costantini, MD, PhD Caroline Pinheiro

Daniele Komar
Curitiba Hospital Cardiologico Costantini (1)
Poland (333)
Country Leaders
Witold Ruzyllo, MD, PhD
Hanna Szwed, MD, PhD
Country Coordinator
Radoslaw Pracon, MD, PhD
Marcin Demkow, MD, PhD
Radoslaw Pracon, MD, PhD
Cezary Kepka, MD PhD Coronary and Structural Heart Diseases Department, Institute of Cardiology (127)
Anna Teresinska, MD PhD Olga Walesiak Warsaw
Karolina Kryczka, MD PhD Katarzyna Malinowska
Jan Henzel, MD PhD
Mateusz Solecki, MD PhD
Edyta Kaczmarska, MD PhD
Jakub Maksym, MD
Karolina Wojtera, MD
Tomasz Mazurek, MD, PhD Anna Fojt, MD Warszawa Medical University of Warsaw (48)
Ewa Szczerba, MD
Szymon Jonik, MD
Jaroslaw Drozdz, PhD
Bartosz Czarniak, MD
Malgorzata Frach (formerly Stasiak), MD Lodz Cardiology Clinic, Medical University in Lodz (43)
Konrad Szymczyk, MD
Iwona Niedzwiecka, MD
Sebastian Sobczak, MD
Tomasz Ciurus, MD
Piotr Jakubowski, MD
Magdalena Misztal-Teodorczyk, MD
Dawid Teodorczyk, MD Marta Swiderek, MA
Aleksandra Fratczak, MD Ewelina Wojtala, MA
Marcin Szkopiak, MD
Patrycja Lebioda, MD
Michal Wlodarczyk, MD
Anna Plachcinska, MD
Jacek Kusmierek, MD
Magdalena Miller, MD
Halina Marciniak, MD
Karolina Wojtczak-Soska, MD
Katarzyna Łuczak, MD
Tomasz Tarchalski, MD
Anna Cichocka-Radwan, MD
Hanna Szwed, MD, PhD Jaroslaw Karwowski, MD Warsaw National Institute of Cardiology, Warsaw (35)
Grazyna Anna Szulczyk, MD
Adam Witkowski, MD, PhD
Krzysztof Kukuła, MD, PhD Warsaw Department of Interventional Cardiology & Angiology, Institute of Cardiology (20)
Małgorzta Celińska-Spodar, MD
Joanna Zalewska, MD
Grzegorz Gajos, MD, PhD Krakow Department of Coronary Disease, John Paul II Hospital, Jagiellonian University Medical College (16)
Krzysztof Bury, MD, PhD
Piotr Pruszczyk, MD, PhD Andrzej Łabyk, MD Warszawa Department of Internal Medicine and Cardiology, Infant Jesus Teaching Hospital, Medical University of Warsaw (15)
Marek Roik, MD, PhD Agnieszka Szramowska, MD
Olga Zdończyk, MD
Krystyna Łoboz-Grudzień, MD, PhD
Leszek Sokalski, MD, PhD Joanna Jaroch, MD, PhD Wrocław T.Marciniak Hospital (11)
Barbara Brzezińska, MD, PhD
Maciej Lesiak, Professor, MD Szpital Kliniczny
Magdalena Łanocha, MD Poznan Przemienienia Pańskiego (10)
Krzysztof W. Reczuch, MD Adam Kolodziej, MD Wroclaw Military Hospital / Medical University (4)
Zbigniew Kalarus, MD Medical University of Silesia, School of Medicine with the Division of Dentistry, Department of Cardiology, Congenital Heart Diseases and Electrotherapy, Silesian Center for Heart Diseases (3)
Andrzej Swiatkowski, MD
Mariola Szulik, MD
Zabrze
Wlodzimierz J. Musial, MD Marta Marcinkiewicz-Siemion, MD Bialystok University Hospital in Bialystok (1)
Russia (303)
Country Coordinator
Olga Bockeria, MD, PhD
Leo Bockeria, MD, PhD Olga Bockeria, MD, PhD National Medical Research Center for Cardiovascuar Surgery (113)
Karen Petrosyan, MD, PhD Zalina Kudzoeva, MD Moscow
Tatiana Trifonova, MD Nodira Aripova, MD
Alexander M. Chernyavskiy, MD, PhD Ivan A. Naryshkin, MD E.Meshalkin National Medical Research Center of the Ministry of Health of the Russian Federation (101)
Evgeniy I. Kretov, MD Alena Kuleshova, MD Novosibirsk
Igor O. Grazhdankin, MD Dastan Malaev, MD
Leonid L. Bershtein, MD, PhD
Sergey A. Sayganov, MD, PhD Irina Subbotina Saint Petersburg North-Western State Medical University (50)
Anastasia M. Kuzmina-Krutetskaya, MD Victoria Gumerova
Elizaveta V. Zbyshevskaya, MD, PhD
Nana O. Katamadze, MD, PhD
Elena A. Demchenko, MD, PhD
Pavel S. Kozlov, MD Olga B. Nikolaeva, MD Saint Petersburg Federal Almazov North-West Medical Research Centre (39)
Vikentiy Y. Kozulin, MD
Ekaterina I. Lubinskaya, MD
*Spain (286)
Country Leader
Jose Luis Lopez-Sendon, MD, PhD
Country Coordinator
Almudena Castro, MD
Jose Lopez-Sendon, MD, PhD
Almudena Castro, MD
Elena Refoyo Salicio, MD Virginia Fernández-Figares, Pharm Madrid Hospital La Paz. IdiPaz (118)
Gabriela Guzman, MD
Gabriel Galeote, MD
Silvia Valbuena, MD
Jesús Peteiro, MD, PhD Complejo Hospitalario Universitario A Coruña (CHUAC) Sergas, Department of Cardiology. INIBIC
María Dolores Martínez-Ruíz, MD
Ruth Pérez-Fernández, MD Moisés Blanco-Calvo, PhD
José J Cuenca-Castillo, MD Encarnación Alonso-Álvarez, BSc A Coruna A Coruña. CIBER-CV. Universidad de A Coruña, Spain (112)
Xacobe Flores-Ríos, MD Paula García-González, BSc
Óscar Prada-Delgado, MD
Gonzalo BargeCaballero, MD
Jose Ramon Gonzalez Juanatey, MD, PhD
Miguel Souto Bayarri, MD, PhD Hospital Clinico Universitario de Santiago (17)
Virginia Pubull Nuñez, MD Jose Seijas Amigo, Pharm Santiago de Compostela
Raymundo Ocaranza Sanchez, MD, PhD
Belen Cid Alvarez, MD
Carlos Peña Gil, MD, PhD
Amparo Martinez Monzonis, MD
Alessandro Sionis, MD
Montserrat Vila Perales, MD
Josep Maria Padró, MD
Antonio Serra Peñaranda, MD
Joan García Picart, MD Ana Fernández Martínez, RN Barcelona Hospital de la Santa Creu i Sant Pau (11)
Antonino Ginel Iglesias, MD
Xavier Garcia-Moll Marimon, MD
Guillem Pons Lladó, MD
Francesc Carreras Costa, MD
Vicente Miro, MD
Jose L Diez, MD Begoña Igual, MD Valencia Hospital Universitario y Politecnico La Fe (10)
Pilar Calvillo, MD
F. Marin Ortuño, MD, PhD
M. Valdés Chávarri, MD, PhD M. Quintana Giner, MD HUVA, Hospital Clínico Universitario Virgen De La Arrixaca (8)
A. Tello Montolliu, MD, PhD A.I. Romero Aniorte, MD Murcia
E. Pinar Bermudez, MD, PhD JM. Rivera Caravaca, MD
G. De La Morena, MD, PhD
Olga Cañavate
Montserrat Gracida Blancas, MD Sonia Guerrero
Silvia Riera
Jose Enrique Castillo
Barcelona Hospital De Bellvitge (4)
Jose Enrique Castillo Luena, MD Luena
Maria Lasala
Zaragoza Hospital Universitario Miguel Servet (4)
Francisco Fernandez-Aviles, MD Maria Lorenzo
Olga Sobrino
Alexandra Vazquez
Madrid Hospital General Universitario Gregorio Maranon (2)
China (246)
Country Leader
Lixin Jiang, MD, PhD
Haojian Dong
Jiyan Chen, MD Peiyu He
Chunli Xia
Guangzhou Guangdong General Hospital (102)
Junqing Yang
Qi Zhong
Yongjian Wu, MD, PhD Yanmeng Tian, MD
Dongze Li
Beijing Chinese Academy of Medical Sciences, Fuwai Hospital (17)
Yitong Ma, MD Xiaomei Li Urumqi First Affiliated Hospital of Xinjiang Medical University (15)
Yining Yang, MD Xiang Ma
Zixiang Yu
Qian Zhao
Chunguang Li
Zheng Ji, MD Lei Zhang
Yu Zhao
Bolin Zhu
Tangshan Tangshan Gongren Hospital (15)
Mulei Chen Beijing Beijing Chao-yang Hospital, Capital Medical University (12)
Xinchun Yang, MD Hongjie Chi
Yang Wang
Jing Zhang
Wenhua Lin, MD Rui Jing
Jingjing Liu
Qiang Zhou, MD
Chang Xu, MD
Tianjing TEDA International Cardiovascular Hospital (12)
Hesong Zeng, MD Zhuxi Li, MD
Junhua Li, MD
Luyang Xiong, MD
Dan Gao
Wuhan Tongji Medical College (11)
Xin Fu, MD Dengke Jiang
Ran Leng
Xutong Wang
Qianqian Yuan
Lili Zhang
Ziliang Bai
Jianhua Li
Jie Qi
Zhengzhou The First Affiliated Hospital of Zhengzhou University (11)
Bin Yang, MD Fei Wang
Haitao Wang
Bin Yang
Zhou Yue
Zhulin Zhang
Yumei Dong
Taiyuan Shanxi Cardiovascular Hospital (10)
Songtao Wang, MD Jiajia Mao
Bin Zhang
Qingdao Qingdao Fuwai Hospital (8)
Gong Cheng, MD Xiuhong Li
Xiaowei Yao
Nier Zhong
Ning Zhou
Xian Shanxi Provincial People’s Hospital (6)
Yulan Zhao, MD Yaping Huang, MS

Panpan Zhou, MS
Zhengzhou The Second Affiliated Hospital of Zhengzhou University (6)
Xuehua Fang, MD Wei Su Beijing Liangxiang Hospital, Beijing Fangshan District (6)
Qiutang Zeng, MD Yu Kunwu
Yudong Peng
Xin Su
Wuhan Wuhan Union Hospital, Tongji Medical College, Huazhong Science and Tech University (3)
Xi Su, MD Chen Wang
Yunhai Zhao
Wuhan Wuhan Asia Heart Hospital (3)
Qingxian Li, MD Yaming Geng
Yanfu Wang
Jing-yao Fan, MD
Si-ting Feng, MD,PhD
Jining Affiliated Hospital of Jining Medical University (3)
Shao-ping Nie, MD, PhD Xiao Wang, MD,PhD
Yan Yan, MD,PhD
Hui-min Zhang, MD,PhD
Beijing Beijing Anzhen Hospital (2)
Qin Yu, MD Lingping Chi

Fang Liu
Dalian Affiliated Zhongshan Hospital of Dalian University (2)
Jian’an Wang, MD Han Chen
Jun Jiang
Huajun Li
Jian’an Wang
Yechen Han, MM
Lihong Xu, RN
Hangzhou The Second Affiliated Hospital Zhejiang University School of Medicine (1)
Shuyang Zhang, MD, PhD Zhenyu Liu Beijing Peking Union Medical College Hospital (1)
Zhenyu Liu, MD Gang Chen
Rongrong Hu
*Italy (139)
Country Leader
Aldo P. Maggioni, MD
Gian Piero Perna, MD
Marco Marini, MD
Francesca Pietrucci, PhD Ancona Cardiology and CCU - Ospedali Riuniti Ancona (54)
Gabriele Gabrielli, MD
Stefano Provasoli, MD
Edoardo Verna, MD
Anna Di Donato Varese Ospedale di Circolo e Fondazione Macchi (23)
Lorenzo Monti, MD

Barbara Nardi, MD
Rozzano Humanitas Research Hospital, Rozzano (MI) (17)
Antonio Di Chiara, MD Francesca Pezzetta, MD Tolmezzo Azienda Servizi Sanitaria n.3 Alto Friuli-Collinare-Medio Friuli (9)
Andrea Mortara, MD
Marcello Galvani, MD
Valentina Casali, MD Monza Policlinico di Monza, Monza MB (8) Ospedale “G.B. Morgagni – L. Pierantoni” Forli (AUSL della Romagna) (8)
Filippo Ottani, MD Chiara Attanasio Forli
Gianpiero Leone, MD
Marco Sicuro, MD Francesco Pisano, MD
Cristina Bare, BSc
Aosta Ospedale Regionale Umberto Parini (5)
Paolo Calabro, MD AORN Dei Colli “V. Monaldi” UOC Cardiologia Università della Campania “L.Vanvitelli” (4)
Tiziana Formisano, MD Fabio Fimiani Napoli
Giuseppe Tarantini, MD Alberto Barioli, MD
Umberto Cucchini, MD
Anto Luigi Andres, MD
Federica Ramani Padua University of Padua-Cardiology Clinic (3)
Emanuela Racca, MD Fabrizio Rolfo, MD
Cecilia Goletto
Cuneo Azienda Ospedaliera S. Croce e Carle (3)
Carlo Briguori, MD Francesca De Micco Naples Clinica Mediterranea (2)
Roberto Amati, MD Stefano Di Marco, MD UO Cardiologia Ospedale SS Cosma e Damiano (2)
William Vergoni, MD Martina Tricoli Pescia
Aldo Russo, MD
Raffaele Fanelli, MD
Massimo Villella, MD San Giovanni Rotondo IRCCS “Casa Sollievo della Sofferenza” (1)
*Singapore (61)
Country Leader
Harvey D. White, DSc
Country Coordinator
Caroline Alsweiler
Kian-Keong Poh, MD
Ping Chai, MD
Joshua P. Loh, MD
Edgar L. Tay, MD
Kristine Teoh, MD
Lynette L. Teo, MD
Sik-Yin V Tan, BSc
Winnie C Sia, BSc
Singapore National University Heart Center Singapore (33)
Ching-Ching Ong, MD
Raymond C. Wong, MD
Poay-Huan Loh, MD
Theodoras Kofidis, MD
David Foo, MBBS
Audrey W Leong, BSc
Jason Loh Kwok Kong, MD
Ching Min Er, MD
Li Hai Yan, RN Singapore Tan Tock Seng Hospital (22)
Fahim Haider Jafary, MD
Terrance Chua, MD Nasrul Ismail
Min Tun Kyaw
Deborah Yip
Singapore National Heart Centre Singapore (6)
Germany (54)
Country Leader
Rolf Doerr, MD
Rolf Doerr, MD
Juergen Stumpf, MD Dorit Grahl
Klaus Matschke, MD, PhD Franziska Guenther Dresden Praxisklinik Herz und Gefaesse (29)
Gregor Simonis, MD, PhD
Clemens T. Kadalie, MD
Kerstin Bonin
Udo Sechtem, MD
Peter Ong, MD
Ina Wenzelburger
Susanne Gruensfelder, RN
Stuttgart Robert-Bosch-Krankenhaus (22)
P. Christian Schulze, MD, PhD Jena University Hospital Jena (2)
Bjoern Goebel, MD
Karsten Lenk, MD
Georg Nickenig, MD Jan-Malte Sinning, MD
Marcel Weber, MD
Nikos Werner, MD
Bonn Universitatsklinikum Bonn (1)
Austria (50)
Country Leaders
Irene Marthe Lang, MD
Kurt Huber, MD
Herwig Schuchlenz, MD
Stefan Weikl, MD
Gudrun Steinmaurer Graz LKH Graz West Austria (35)
Irene Marthe Lang, MD Max-Paul Winter, MD Vienna Medical University of Vienna, Department of Cardiology (8)
Kurt Huber, MD Tijana, Andric, MD
Maximilian, Tscharre, MD
Gabriele, Jakl-Kotauschek, MD Claudia, Wegmayr, MSc
Bernhard, Jäger, MD
Florian, Egger, MD
Vienna Wilhelminen Hospital Vienna (7)
Hungary (49)
Country Leader
Matyas Keltai, MD, PhD, DSc
Judit Sebo, MD
Andras Vertes, MD Zoltan Davidovits, MD Budapest Eszszk- Szent Istvan Hospital (20)
Albert Varga, MD, PhD Laszlone Matics Gergely Ágoston, MD Szeged University of Szeged (12)
Geza Fontos, MD Gabor Dekany, MD Budapest George Gottsegen National Institute of Cardiology (9)
Bela Merkely, MD, PhD, DSc Andrea Bartykowszki, MD
Pal Maurovich-Horvat, MD, PhD, MPH
Budapest Heart and Vascular Center, Semmelweis University (8)
Serbia (47) Gabor Kerecsen, MD Agnes Jakal Budapest Military Hospital, Budapest (1)
Sasa Hinic, MD, BSc
Jelena Djokic, MD Belgrade
Marija Zdravkovic, MD, PhD
Vladan Mudrenovic, MD
Bogdan Crnokrak, MD
University Hospital Center Bezanijska Kosa (13)
Branko D. Beleslin, MD, PhD
Nikola N. Boskovic, MD
Marija T. Petrovic, MD
Ana D. Djordjevic-Dikic, MD, PhD
Vojislav L. Giga, MD, PhD
Belgrade Faculty of Medicine, University of Belgrade; Cardiology Clinic, Clinical Center of Serbia (10)
Milan R. Dobric, MD Jelena J. Stepanovic, MD, PhD
Zeljko Z. Markovic, MD, PhD
Ana S. Mladenovic, MD, PhD
Lazar Velicki, MD Institute of Cardiovascular Diseases Vojvodina, Sremska Kamenica, Serbia and Faculty of Medicine, University of Novi Sad (9)
Nada Cemerlic-Adjic, MD Ljiljana Pupic Sremska Kamenica
Goran Davidović, MD, PhD
Rada Vučić, MD
Stefan M. Simović, MD Kragujevac Clinical Center Kragujevac (7)
Milica Nikola Dekleva, MD PhD Miroslav Stevo Martinovic, MD
Gordana Stevanovic
Belgrade University Clinical Hospital Zvezdara (6)
Goran Stankovic, MD Milan Dobric Belgrade Clinical Center of Serbia (1)
Svetlana Apostolovic, MD Sonja Salinger Martinovic
Dragana Stanojevic
Nis Clinic for Cardiovascular Diseases, Clinical Center Nis (1)
Mexico (46) Jorge Escobedo, MD
Rubén Baleón-Espinosa, MD
Arturo S Campos-Santaolalla, MD Elihú Durán-Cortés, MD
José M Flores-Palacios, MD
Andrés García-Rincón, MD
Moisés Jiménez-Santos, MD
Joaquín V Peñafiel, MD
Ramon de Jesús- Pérez, RN Benito Juarez Instituto Mexicano del Seguro Social (35)
José A Ortega-Ramírez, MD
Aquiles Valdespino-Estrada, MD
Erick Alexánderson Rosas, MD María Fernanda Canales Brassetti, MD
Diego Adrián Vences Anaya, MD
María Pérez García Isabel Estela Carvajal Juarez, MD
Magdalena Madero Rovalo, MC
Erick Donato Morales Rodríguez, MD
Mexico City Instituto Nacional de Cardiología “Ignacio Chávez” (11)
Australia (45)
Country Leaders
Joseph B. Selvanayagam, MBBS (Hons), DPhil
Jamie Rankin, MBBS (past)
Country Coordinator
Deirdre Murphy
Joseph B. Selvanayagam, MBBS (Hons), DPhil
Majo X. Joseph, MBBS
Sau Lee, PhD
Prince Thomas, RN
Melissa D Chaplin, RN
Adelaide Flinders Medical Centre (30)
Suku T. Thambar, MBBS Stephanie C Boer, B Biotechnology (Honours) New Lambton Heights John Hunter Hospital (8)
John F. Beltrame, MD Jeanette K. Stansborough, RN
Marilyn Black, RN
Michelle M. Bonner, B. Nursing
Woodville The Queen Elizabeth Hospital (5)
Graham S. Hillis, PhD Kim F. Ireland, RN
Clare Venn-Edmonds, RN
South Perth Royal Perth Hospital (2)
France (42)
Country Leader
Philippe-Gabriel Steg, MD
Country Coordinators
Helene Abergel
Jean-Michel Juliard
Christophe Thuaire, MD
Téodora Dutoiu, MD
Corine Thobois, RN
Emilie Tachot, RN
Christophe Laure, RN
Christel Vassaliere, RN
Chartres C.H. Louis Pasteur (21)
Philippe Gabriel Steg, MD
Jean-Michel Juliard, MD
Helene Abergel, MSc
Axelle Fuentes, MSc
Paris Bichat Hospital (9)
Michel S. Slama, MD Ludivine Eliahou, MD
Olivier Dubourg, MD
Clamart Cedex Antoine-Beclere Hospital (5)
Rami El Mahmoud, MD Pierre Michaud, MD Boulogne Ambroise Pare Hospital (2)
Eric Nicollet, MD Sarah Hadjih Corbeil-Essonnes Cedex Centre Hospitalier Sud Francilien (2)
Pascal Goube, MD Patricia Brito
Gilles Barone-Rochette, MD Gilles Barone-Rochette Grenoble Grenoble University Hospital (2)
Alain Furber, MD
Loïc Bière, MD
Charles Cornet, MD, PhD
Jeremy Rautureau, MD, PhD
Angers Cedex 9 Centre Hospitalier Universitaire d’Angers (1)
Lithuania (39) Agne Juceviciene, MD
Irma Kalibataite-Rutkauskiene, MD
Laura Keinaite
Aleksandras Laucevicius, MD
Jelena Celutkiene, MD
Monika Laukyte
Gelmina Mikolaitiene
Akvile Smigelskaite, MD
Ilona Tamasauskiene, MD
Agne Urboniene, MD
Vilnius Vilnius University Hospital Santariskes Clinic (39)
*Netherlands (37)
Elvin Kedhi MD, PhD
Jorik Timmer, MD
Rik Hermanides, MD
Ilse Bouwhuis Eliza Kaplan, MD
Robert K. Riezebos,
Lia Nijmeijer Zwolle Isala Klinieken (25)
MD, PhD
Pouneh Samadi, MD
Jeannette, J. M. Schoep, RN Cardio Research Amsterdam Hartcentrum OLVG (11)
Elise van Dongen, MD
Sander R. Niehe, MD
Harry Suryapranata, MD
Elisabeth, M. Janzen, RN
Stijn van Vugt, MD, PhD Sandra Ahoud Nijmegen Radboudumc (1)
Portugal (33)
Ruben Ramos, MD
Duarte Cacela, MD
Ana Santana, MD
Antonio Fiarresga, MD
Lidia Sousa, MD
Hugo Marques, MD
Lino Patricio, MD Mafalda Selas
Luis Bernanrdes, MD Filipa Silva Lisbon Hospital de Santa Marta (25)
Pedro Rio, MD Cláudia Freixo
Ramiro Carvalho, MD
Rui Ferreira, MD
Tiago Silva, MD
Ines Rodrigues, MD
Pedro Modas, MD
Guilherme Portugal, MD
Jose Fragata, MD
Fausto J. Pinto, PhD Inês Zimbarra Cabrita, PhD
Miguel Nobre Menezes, MD Andreia Rocha, MSc
Guilhermina Cantinho Lopes, MD Francisca Patuleia Figueiras, PhD Santa Maria University Hospital, Cardiology Department, CHLN (6)
Ana Gomes Almeida, PhD Andreia Coelho, BSc Lisbon
Pedro Canas Silva, MD Marta Capinha
Angelo Nobre, MD Maria Inês Caetano
Ana Rita Francisco, MD Susana Silva
Nuno Ferreira, MD
Ricardo L. Lopes, MD Vila Nova de Gaia Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE (2)
Argentina (29)
Country Leader
Rafael Diaz, MD (past)
Luis Guzman, MD Veronica Tinnirello Cordoba Instituto Medico DAMIC (11)
Julio César Figal, MD
Oscar Méndiz, MD
Claudia Cortés, MD
Matías Nicolás Mungo Ciudad Autonoma de Buenos Aires Fundación Favaloro (10)
Roberto René Favaloro, MD
Carlos Alvarez, MD Marina Garcia Bahia Blanca Hospital Italiano Regional del Sur Bahia Blanca (3)
Javier Courtis, MD
Gabriela Zeballos, MD
Valeria Godoy Cordoba Clinica Romagosa and Clinica De La Familia (2)
Lilia Schiavi, MD Maria Victoria Actis Cordoba Clinica Del Prado (2)
Mariano Rubio, MD Graciela Scaro, MD Cordoba Clínica Privada Vélez Sarsfield (1)
*New Zealand (28)
Country Leader
Harvey D. White, DSc
Country Coordinator
Caroline Alsweiler
Gerard Patrick Devlin, MD Liz Low, RN
Raewyn Fisher, MD Jayne Scales, RN Hamilton Waikato Hospital (22)
Kirsty Abercrombie, RN
Ralph Alan Huston Stewart, MB,ChB, MD Leah Howell, RN Auckland City Hospital (6)
Harvey D. White, DSc
Jocelyne Benatar, MD
Cathrine Patten, RN Auckland
*Macedonia (28)
Sasko Kedev, MD, PhD
Irena Peovska Mitevska, MD, PhD
Skopje University Clinic of Cardiology (28)
Elizabeta Srbinovska Kostovska, MD, PhD
Hristo Pejkov, MD, PhD
*Sweden (23)
Country Leader
Claes Held, MD, PhD
Claes Held, MD, PhD
Kai Eggers, MD, PHhD
Gunnar Frostfelt, MD, PhD
Nina Johnston, MD, PhD
Maciej Olsowka, MD
Axel Åkerblom, MD, PhD
Inga Soveri, MD, PhD
Christina Björklund, RN
Maria Andreasson, RN
Marie Essermark, RN
Uppsala Uppsala University (18)
Johannes Aspberg, MD Liselotte Persson Stockholm Karolinska Institutet at Danderyd Hospital (5)
Israel (15)
Country Leaders
Rafael Beyar, MD, MD, DSc, MPH
Tali Sharir, MD
Country Coordinator
Eugenia Nikolsky, MD
Tali Sharir, MD
Dan Elian, MD
Or Harel, MA Tel-Aviv Assuta Medical Centers (9)
Arthur Kerner, MD
Samia Massalha, MD
Margalit Bentzvi
Ludmila Helmer
Haifa Rambam Medical Center (6)
Japan (14)
Country Leader
Shun Kohsaka, MD
Keiichi Fukuda, MD, PhD Ikuko Ueda, PhD Shinjuku-ku Keio University (7)
Shun Kohsaka, MD Jun Fujita, MD
Satoshi Yasuda, MD, PhD

Kanae Hirase, RN
Akemi Furukawa, RN
Toshiyuki Nagai, MD, PhD
Fumiyuki Otsuka, MD, PhD
Suita-shi National Cerebral and Cardiovascular Center (4)
Shigeyuki Nishimura, MD Shintaro Nakano Hidaka Saitama Medical University (3)
*Belgium (7)
Country Leader
Frans Van de Werf, MD, PhD
Country Coordinator
Kaatje Goetschalckx, MD
Kaatje Goetschalckx, MD
Frans Van de Werf, PhD, MD
Kathleen Claes, PhD, MD
Valerie Robesyn Leuven University Hospital Leuven (7)
*Taiwan (7)
Country Leader
Harvey D. White, DSc
Country Coordinator
Caroline Alsweiler
Chung-Lieh Hung, MD
Chun-Ho Yun, MD
Charles Jia-Yin Hou, MD
Jen-Yuan Kuo, MD
Hung-I Yeh, MD, PhD
Ta-Chuan Hung, MD
Jiun-Yi Li, MD, PhD Yi-Hsuan Yang Taipei City Mackay Memorial Hospital (7)
Chen-Yen Chien, MD, PhD
Cheng-Ting Tsai, MD
Chun-Chieh Liu, MD
Fa-Chang Yu, MD
Yueh-Hung Lin, MD
Wei-Ren Lan, MD
Chih-Hsuan Yen, MD
Jui-Peng Tsai, MD
Kuo-Tzu Sung, MD
*South Africa (7)
Mpiko Ntsekhe, MD
Shaheen Pandie, MD Constance Philander (Nee Talliard), ND Noloyiso Mtana, RN Cape Town Groote Schuur Hospital / University of Cape Town (7)
Charle A Viljoen, MD
Marianne De Andrade, MD
*Switzerland (7)
Country Leader
Aldo P. Maggioni, MD
Tiziano Moccetti, MD Adriana Anesini, RN Cardiocentro (7)
M.Grazia Rossi, MD Simona Maspoli, RN Lugano
Manuela Mombelli, RN
Egypt (6)
Magdy Abdelhamid, MD
Ahmed Adel, MD
Ahmed Kamal, MsC
Hossam Mahrous, MD Ahmed Talaat, MD Cairo Cairo University (6)
Sameh El Kaffas, MD
Hussien El Fishawy, MD
Romania (5)
Calin Pop, MD, PhD Emergency County Hospital Baia Mare (4)
Matei Claudia, MD, PhD Bucharest
Bogdan A. Popescu, MD, PhD
Carmen Ginghina, MD, PhD Monica Rosca, MD, PhD Bucharest Emergency Institute of Cardiovascular Diseases “Prof. Dr. C. C. Iliescu” (1)
Dan Deleanu, MD, PhD Carmen C. Beladan, MD, PhD
Vlad A. Iliescu, MD, PhD
*Saudi Arabia (5)
Mouaz H. Al-Mallah, MD MSc Sarah Zahrani, RN Central Province King AbdulAziz Cardiac Center (5)
Ahmed Aljzeeri, MD
Hani Najm, MD
Ali Alghamdi, MD
*Peru (4)
Walter Enrique Mogrovejo Ramos, MD Marco Antonio Monsalve Davila, RN Mirafloes Instituto Neuro Cardiovascular De Las Americas (4)
Thailand (3)
Country Leader
Harvey D. White, DSc
Country Coordinator
Caroline Alsweiler
Srun Kuanprasert, MD
Arintaya Prommintikul, MD
Weerachai Nawarawong, MD Supatchara Khwakhong, RN
Surin Woragidpoonpol, MD Anong Chaiyasri, RN
Thitipong Tepsuwan, MD Warangkana Mekara, RN Chiang Mai Maharaj Nakorn Chiang Mai Hospital (2)
Noppon Taksaudom, MD Supap Kulthawong, RN
Chataroon Rimsukcharoenchai, MD Anong Amaritakomol, RN
Juntima Euathrongchit, MD
Yutthaphan Wannasopha, MD
Sukit Yamwong, MD
Piyamitr Sritara, MD
Suthara Aramcharoen, MD Pachara Panpunuan, RN Bangkok Ramathibodi Hospital (1)
Krissada Meemuk, MD
*Malaysia (2)
Country Leader
Harvey D. White, DSc
Country Coordinator
Caroline Alsweiler
Ahmad Khairuddin, MD Noor Syamira Mokhtar, RN Kuala Lumpur Institut Jantung Negara (2)
Hafidz Abd Hadi, MD Nor Asiah Basri, RN
Shaiful Azmi Yahaya, MD Irni Yusnida, RN
Humayrah Hashim
*

Countries participated in Economics Quality of Life (EQoL) Questionnaires

**

This site received one participant in transfer that was randomized at another site

Footnotes

*

past members / past organizations

**

deceased

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Task Force M, Montalescot G, Sechtem U et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949–3003. [DOI] [PubMed] [Google Scholar]
  • 2.Fihn SD, Gardin JM, Abrams J et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2012;126:e354–471. [DOI] [PubMed] [Google Scholar]
  • 3.Maron DJ, Hochman JS, Reynolds HR et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. The New England journal of medicine 2020;382:1395–1407. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Mahajan N, Polavaram L, Vankayala H et al. Diagnostic accuracy of myocardial perfusion imaging and stress echocardiography for the diagnosis of left main and triple vessel coronary artery disease: a comparative meta-analysis. Heart 2010;96:956–66. [DOI] [PubMed] [Google Scholar]
  • 5.Group ITR, Maron DJ, Hochman JS et al. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design. Am Heart J 2018;201:124–135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Boden WE, O’Rourke RA, Teo KK et al. Optimal medical therapy with or without PCI for stable coronary disease. The New England journal of medicine 2007;356:1503–16. [DOI] [PubMed] [Google Scholar]
  • 7.Group BDS, Frye RL, August P et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. The New England journal of medicine 2009;360:2503–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T, Passamani E, Norris R, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994. Aug 27;344(8922):563–70. [DOI] [PubMed] [Google Scholar]
  • 9.Maron DJ, Stone GW, Berman DS et al.Is cardiac catheterization necessary before initial management of patients with stable ischemic heart disease? Results from a web-based survey of cardiologists. Am Heart J 2011;162:1034–1043. [DOI] [PubMed] [Google Scholar]
  • 10.Xie JX, Eshtehardi P, Varghese T et al. Prognostic Significance of Nonobstructive Left Main Coronary Artery Disease in Women Versus Men: Long-Term Outcomes From the CONFIRM (Coronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter) Registry. Circulation Cardiovascular imaging 2017;10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Oviedo C, Maehara A, Mintz GS et al. Intravascular ultrasound classification of plaque distribution in left main coronary artery bifurcations: where is the plaque really located? Circulation Cardiovascular interventions 2010;3:105–12. [DOI] [PubMed] [Google Scholar]
  • 12.Mancini GBJ, Leipsic J, Budoff MJ et al. Coronary CT Angiography Followed by Invasive Angiography in Patients With Moderate or Severe Ischemia-Insights From the ISCHEMIA Trial. JACC: Cardiovascular Imaging 2021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Berman DS, Kang X, Slomka PJ et al. Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease. J Nucl Cardiol 2007;14:521–8. [DOI] [PubMed] [Google Scholar]
  • 14.Sareen N, Ananthasubramaniam K. Left main coronary artery disease: A review of the spectrum of noninvasive diagnostic modalities. J Nucl Cardiol 2016;23:1411–1429. [DOI] [PubMed] [Google Scholar]
  • 15.Attenhofer CH, Pellikka PA, Oh JK, Roger VL, Sohn DW, Seward JB. Comparison of ischemic response during exercise and dobutamine echocardiography in patients with left main coronary artery disease. Journal of the American College of Cardiology 1996;27:1171–7. [DOI] [PubMed] [Google Scholar]
  • 16.Hochman JS Reynolds HR,Bangalore S et al. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial. JAMA Cardiol 2019;4(3):273–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Rink LD, Feigenbaum H, Godley RW et al. Echocardiographic detection of left main coronary artery obstruction. Circulation 1982;65:719–24. [DOI] [PubMed] [Google Scholar]

RESOURCES